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ABSTRACT
Donald T. Fox: Regulation of epithelial morphogenesis
by Drosophila Rho GTPase and Abl kinase
(Under the direction of Dr. Mark Peifer)
The goal of embryogenesis is to convert a fertilized egg into an adult.  To ensure that
this process occurs normally, regulatory proteins act on the structural elements of a cell to
change its position or shape.  The resulting changes at a cellular level are coordinated within
tissues and constitute a process termed morphogenesis.  To date, many morphogenesis
regulators have been identified in many model systems.  The current aim is to understand
how each regulator interacts with the others and with the structural elements of the cell such
as the cell adhesion machinery and the cytoskeleton.  In my thesis work, I have utilized
epithelial development in Drosophila embryos as a model to investigate functions of the
morphogenesis regulators Rho1 GTPase and Abelson (Abl) kinase.
Rho GTPases have been linked to both regulation of cell-cell adhesion at adherens
junctions (AJs) and the actin cytoskeleton.  With respect to adhesion, conflicting evidence
exists concerning how Rho interacts with core AJ components and the accessory AJ protein
p120-catenin (p120).  As part of my thesis work, I examined the role of Drosophila Rho1
during epithelial morphogenesis.  I found that Rho1 function is not dependent on p120, but
that Rho1 regulates core AJ components.  Further, my work suggests a mechanistic role for
Rho1 in trafficking of the AJ protein cadherin.
The second major area of my work examined the role of the non-receptor tyrosine
kinase Abl during Drosophila morphogenesis.  I identified a novel role for Abl in a specific
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type of apical cell shape change.  Abl is required for apical constriction of mesodermal cells
during gastrulation.  Abl’s regulation of its target Enabled and, consequently, the apical actin
cytoskeleton is crucial for this function.  This observation led me to test the roles of other
ventral furrow regulators in apical actin regulation.  I found that RhoGEF2 but not
Concertina (G-alpha 12/13) also regulates apical actin during ventral furrow formation,
possibly clarifying the difference in phenotypes of mutants of these two morphogenesis
regulators.  Finally, I developed and characterized new tools for studying Abl localization
and activation.  Overall, these studies will aid in efforts in understanding how to build an
animal.
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CHAPTER 1
HOW TO BUILD AN ANIMAL: THE REGULATION OF MORPHOGENESIS
From the point of view of a developmental biologist, the most exciting time of your
life occurs before you are even born.  From fertilization to birth, embryonic development
involves the dynamic forming and rearranging of the tissues that will make up the adult body
plan.  The question of how an animal is built is the fundamental question of developmental
biology.  To understand this process at a molecular level, one must consider the interactions
between the various parts that shape and reshape an embryo. Because the unit of tissue
structure is the cell, we must consider what gives a cell its shape.  Further, we need to
understand how a cell associates with its neighbors to undergo coordinated rearrangements in
tissue structure.  Finally, we must identify and characterize the roles of signaling proteins that
instruct a cell to alter its shape or position.  In this era of largely annotated genome
sequences, what developmental biologists have to work with is a “parts list” for the assembly
of an animal.  The daunting but achievable task now is to figure out how the parts work
together to mold the embryo into the adult structure.
In the Peifer lab, we have approached this problem by observing Drosophila
embryogenesis.  In addition to the wealth of genetic tools in this system, the Drosophila
embryo provides an excellent model to observe the role of candidate morphogenesis
regulators.  During embryogenesis, a number of distinct cell shape changes occur at specific
times and locations.  These morphogenetic events closely mirror processes that occur in
2mammals, such as apical cell constriction.  As the term morphogenesis encompasses a
myriad of processes in many tissue types, we have limited our focus to those involving cells
of the epidermis.  At a molecular level, we have focused our attention on proteins that act in
the apical domain of cells.  At this subcellular location, a hub of protein activity resides at the
cell-cell adhesion complex known as the adherens junction.  Adherens junctions are closely
coupled to the actin cytoskeleton and are the location of many signaling proteins.  Thus,
understanding the interaction between adherens junctions, the cytoskeleton, and signaling
proteins during fly embryogenesis can serve as a microcosmic model of morphogenesis.
During my time in the Peifer lab, I have focused on the role of two signaling proteins
with ties to adherens junction and cytoskeletal regulation.  I evaluated the role of the small
GTPase Rho1 as an adherens junction regulator in Drosophila and determined whether, as in
cultured mammalian cells, Drosophila Rho1 is regulated by the adherens junction protein
p120-catenin (p120).  Additionally, I examined the role of the non-receptor tyrosine kinase
Abelson (Abl) during Drosophila morphogenesis.  As part of this analysis, I characterized
Abl’s localization and activation.    I also contributed to work concerning the role of p120 at
adherens junctions and the function of Abl prior to morphogenesis.
The nuts and bolts
The first components to consider when building an animal are structural proteins.
These proteins dictate cell shape and help to organize cells within tissues.  The two main
classes of these “nuts and bolts” parts are cell adhesion complexes and the cytoskeleton.
These structural elements are often functionally linked to one another, as the actin
cytoskeleton is to adherens junctions (reviewed in Gates and Peifer, 2005).  Cell adhesion
3and cytoskeletal proteins can hardly be thought of as rigid structures.  Rather, both are quite
dynamic and undergo turnover and rearrangements to allow for cell shape change and
migration.  In my thesis work, I focused on cell adhesion at adherens junctions and the
interaction of this complex with the actin cytoskeleton.
Cell adhesion at adherens junctions
The adherens junction is a critical cell-cell adhesion complex in epithelial cells.  This
highly conserved complex consists of three core components: cadherin and two catenin
proteins, alpha and beta (Fig. 1).  Cell-cell contact is mediated by the extracellular domain of
Cadherin, which binds calcium and mediates homophilic contacts with extracellular domains
of cadherins of a neighboring cell.  Within the cell, the cytoplasmic tail of cadherin binds to
beta-catenin.  Beta-catenin also binds alpha-catenin, which can bind actin (reviewed in
Gumbiner, 1996).  While this cadherin-catenin complex has been thought to bind to actin,
recent evidence suggests that alpha-catenin can bind to beta-catenin or to actin, but not both
at once (Drees et al, 2005; Yamada et al, 2005).  Nevertheless, cell-cell adhesion at adherens
junctions certainly influences the activity of the actin cytoskeleton.
Another component of adherens junctions is the catenin p120.  Originally identified
as a substrate of Src kinase, p120 binds to the cadherin tail proximal to the site of beta-
catenin binding (Fig. 1, reviewed in Anastasiadis and Reynolds, 2000).  While
overexpression studies in cultured mammalian cells originally described both positive and
negative roles for p120 in cell adhesion, siRNA knockdown studies overwhelmingly argue
for a positive role of p120 in strengthening adhesion at adherens junctions (Davis et al, 2003;
Xiao et al, 2003).  Outside of junctions, mammalian p120 has been implicated in other
cellular functions.  Cytoplasmic p120 has been connected to the negative regulation of Rho
4GTPase, while nuclear p120 seems to play a role in transcription (reviewed in Anastasiadis
and Reynolds, 2000).
Contrary to the name, cell adhesion is not cell glue.  Rather, cell adhesion is
frequently remodeled to accomplish many morphogenetic events.  For example, adherens
junctions can expand to change the circumference of a cell, as during zebrafish epiboly
(Kane et al, 2005) or expansion of the Drosophila trachea (Beitel and Krasnow, 2000).
Decreased cell adhesion can also contribute to morphogenesis.  Down-regulation of cadherin
in a group of cells can create differential cell adhesion between those cells and the rest of a
tissue.  Such alterations in cell adhesion may allow for sorting of that group of cells out of
the tissue, as during epithelial to mesenchymal transitions (reviewed in D'Souza-Schorey,
2005).  A third way in which dynamic cell adhesion can contribute to morphogenesis occurs
during cell migration.  In both gastrulating Xenopus embryos and migrating border cells of
Drosophila ovaries, the turnover of adhesive contacts between migrating cells and their
substrate allows for making and breaking of adhesive bonds which drive cell migration
(Geisbrecht and Montell, 2002).
Cell adhesion can also indirectly influence morphogenesis by acting as an upstream
signal for cytoskeletal remodeling.  Given its association with the actin cytoskeleton, it is not
surprising that adherens junctions are implicated in actin regulation.  Alpha-catenin appears
to functionally interact with both formins (Kobielak et al, 2004) and Ena/VASP proteins
(Vasioukhin et al., 2000), which regulate actin polymerization at adherens junctions.
Further, cadherin-cadherin ligation has been shown to stimulate the activity of Rho family
GTPases, known for their roles in actin reorganization (reviewed in Yap and Kovacs, 2003).
The Actin Cytoskeleton
5While cell adhesion coordinates changes within a tissue, the force behind cell shape
change is driven by the actin cytoskeleton.  Polymerized filaments of actin are assembled by
the addition of monomers into the growing or barbed end of an existing filament.  The
formation of new filaments is accomplished by nucleating proteins such as the Arp 2/3
complex or formins.  The active assembly and disassembly of actin filaments is critical
during cell migration (reviewed in Pollard and Borisy, 2003).
  Polymerized F-actin filaments are not simply linear in structure but tend to be
branched.  Work in cultured mammalian cells has identified a mechanism for regulating the
degree of actin branching.  This work revealed that competition for barbed ends occurs
between the Ena/VASP family of proteins, which promote the growth of an existing filament,
and capping proteins, which block the further addition of monomers to one filament, thus
forcing branched nucleation of new filaments (Bear et al, 2002).  At the cellular level,
branched and unbranched structures form cell protrusions called lamellipodia and filopodia
that are key in cell migration (reviewed in Reinhard et al., 2001).
Another way to regulate actin structure is through contraction of filaments.  Myosin II
is the major motor involved in contraction of actin.  Myosin II consists of a hexamer of two
heavy, two essential light, and two regulatory light chains.  In an ATP-dependent process,
myosin slides actin filaments together (reviewed in Craig and Woodhead, 2006).  Actin-
myosin contraction contributes to a number of morphogenetic processes, such as the apical
constriction that invaginates cells of the vertebrate neural tube or the mesoderm of the fly
embryo.  Such contraction also plays a conserved role during both Drosophila dorsal closure
and zebrafish epiboly (Koppen et al., 2006), where sheets of epithelial cells are pulled
together.
6Rearranging the pieces
Embryonic morphogenesis encompasses many events, most of which likely involve
cell adhesion and the cytoskeleton.  The question then is how a group of cells in a tissue
executes one morphogenetic change versus another.  One hypothesis is that the nuts and bolts
pieces are rearranged by a set of regulatory proteins specific to one process.  For adherens
junctions, these players are the many signaling proteins that interact with this complex.  Two
examples of these regulatory proteins are the small GTPase Rho and the non-receptor
tyrosine kinase Abl.
Rho GTPase
Rho small (not heterotrimeric) GTPases are often described as “molecular switches.”
These proteins cycle between GDP-bound “off” and GTP-bound “on” states.  In the on state,
the active GTPase interacts with an effector protein.  The Rho family of GTPases consists of
Rho, Rac, and Cdc42 proteins.  Classic studies in mammalian fibroblasts implicated each
type of Rho GTPase in a different aspect of actin structure regulation.  While Rho promotes
actin stress fiber formation, Rac contributes to lamellipodial actin and Cdc42 to filopodial
actin formation (Ridley and Hall, 1992, Ridley et al, 1992, Nobes and Hall, 1995.  Since
these studies, Rho family GTPases have been implicated in almost every cellular process,
from mitosis to polarity to transcription.  Specificity of Rho GTPase function is conferred by
the activity of numerous Rho regulatory proteins.  GEF proteins promote the active Rho state
by exchanging GDP for GTP.  Conversely, GAP and GDI proteins promote the inactive state
by promoting GTP hydrolysis and sequestering GDP-bound Rho proteins, respectively
(reviewed in Moon and Zheng, 2003).
7While the effects of Rho on actin structure is clear, Rho’s interaction with cell
adhesion at adherens junctions is not as well understood.  Drosophila Rho1 has been shown
to bind directly to both alpha-catenin and p120 (Magie et al., 2002).  Further, Rho appears to
contribute to some of the same morphogenetic processes that involve adherens junction
regulation, such as dorsal closure in Drosophila (Bloor and Kiehart, 2002).  However, the
exact relationship between Rho and adherens junctions is unclear, as mis-expression studies
in both flies and cultured cells suggest both positive and negative roles for Rho in adherens
junction regulation (reviewed in Perez-Moreno et al., 2003).  As part of my thesis work, I
used loss of function, rather than mis-expression analysis, to determine whether Drosophila
Rho1 is an adherens junction regulator.  Further, I tested the hypothesis that, as in
mammalian cells, p120 regulates Rho1 function.
Abl Kinase
Another candidate piece mover in morphogenesis is the non-receptor tyrosine kinase
Abl.  Like Rho GTPases, Abl also exists in active and inactive states.  Non-receptor tyrosine
kinases may share a conserved mechanism of activation, as comparison of the crystal
structures of Src and Abl kinases suggests.  These proteins adopt a folded confirmation in the
inactive state which obscures protein interaction domains and activating residues.  A series of
activation events then unfolds the kinase, allowing it to interact with effector proteins
(reviewed in Harrison, 2003).
Tyrosine phosphorylation plays a major role in adhesion at adherens junctions.  Such
phosphorylation is thought to alter the ability of junctions to assemble, and mis-regulated
adhesion is implicated as a step to cancer invasiveness (reviewed in Gumbiner, 2005).
Studies in cultured mammalian cells have linked non-receptor tyrosine kinase signaling to
8regulation of cadherin-mediated adhesion (reviewed in Gumbiner, 2005).  In Drosophila, Abl
has been implicated in the regulation of adherens junctions.  Drosophila abl genetically
interacts with shotgun (E-cadherin) mutants and regulates the localization of the single
Ena/VASP homologue, which co-localizes with adherens junctions (Grevengoed et al., 2003;
Grevengoed et al., 2001).  Abl loss of function in Drosophila also disrupts morphogenetic
processes that require adherens junction function, such as dorsal closure and head involution.
While the above evidence connects Abl to regulation of adhesion, Abl may also act
more directly on the actin cytoskeleton.  Unlike its close relative Src, Abl family kinases
contain a long C-terminal region that can bind to both filamentous and monomeric actin.
Mammalian Abl-related gene (Arg) can bundle actin filaments in vitro, and expression of Abl
or Arg in cultured mammalian cells causes rearrangement of the actin cytoskeleton (reviewed
in Hernandez et al., 2004).  Loss of Abl in both fly and mouse embryos disrupts a number of
morphogenetic processes, which coincide with a change in actin localization (Grevengoed et
al., 2001; Koleske et al., 1998).  Among the many Abl substrates are the Ena/VASP proteins.
In early Drosophila embryos, loss of Abl results in ectopic Ena localization, resulting in
ectopic apical actin-rich microvilli at the expense of basal actin in membrane furrows.  This
phenotype is rescued by reduction in the dose of Ena (Grevengoed et al., 2003).
While the above work ties Abl function to morphogenesis and actin regulation, it is
not clear when and where Abl activity is needed and, of equal importance, not needed.  In my
thesis work, I have examined Abl’s role in Drosophila morphogenesis in detail.  As part of
this analysis, I developed and made use of new Abl localization tools to observe where and
when total and active Abl protein localizes.  Additionally, I have initiated studies on
identifying potential upstream activators of fly Abl, following up on the observation from
9cultured mammalian cells that Abl is activated by receptor tyrosine kinases and Src
(reviewed in Hernandez et al., 2004).
Epithelial morphogenesis in the Drosophila embryo: a quick tour
The Drosophila embryo provides an excellent model for observing morphogenetic
events.  The role of the “nuts and bolts” players has been examined in many of these
processes.  Embryogenesis lasts 24 hours and can be broken up into several distinct stages.
The embryo begins as a syncytium during the blastoderm (Fig. 2A).  A group of nuclei in this
early embryo migrate to the surface and continue to divide.  When this population reaches
approximately 6,000 nuclei, each nucleus is simultaneously enclosed in a single membrane in
a process known as cellularization (time to this point- 3 hours @ 25°C).  Disruption of the
actin cytoskeleton can inhibit cellularization (Planques et al., 1991).  However, to this point,
adherens junctions are dispensable for development (Cox et al., 1996; Grevengoed et al
2003).  Thus, epithelial morphogenesis truly initiates after cellularization with the onset of
gastrulation.
Gastrulation involves the internalization of the mesoderm and posterior midgut cells
(Fig. 2B, arrow) as well as the elongation of the embryo in the A-P axis, a process referred to
as germband extension (Fig. 2B,C).  Cell shape changes during gastrulation consist of apical
constrictions in the mesoderm and posterior midgut, as well as cell-cell intercalation in the
germband.  Apical myosin II localization appears key for apical constriction during
gastrulation and other such cell shape changes in the embryo (Nikolaidou et al 2004).
Further, adherens junctions are thought to act as a link to the contractile myosin network
during constriction (Dawes-Hoang et al., 2005).  Adherens junctions also rearrange cell-cell
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contacts to allow cell intercalation in the extending germband (Bertet et al., 2004).  During
germband extension, segmentation of the embryo begins to be apparent (Fig. 2C, time to
fully extended germband- 9 hours @ 25°C).
During germband extension a new cell type emerges on the surface of the embryo
known as the amnioserosa (Fig. 2D, star).  This tissue dramatically changes shape and
encompasses most of the dorsal surface of the embryo during a process known as germband
retraction.  The amnioserosa then constricts, cooperating with a force in the neighboring
“leading edge” epithelial cells (Fig. 2D, arrow), which assemble an actin-myosin rich cable
around the periphery of the amnioserosa.  The combination of amnioserosal and leading edge
forces counteracts a resistance force in the more lateral epithelia as the epidermis gradually
moves dorsal to cover the amnioserosa in a process known as dorsal closure (Hutson et al
2003; Kiehart et al 2000).  In addition to a requirement for actin and myosin, adherens
junctions are also needed for dorsal closure (McEwen et al., 2000).
As dorsal closure finishes (Fig. 2E, arrow, time to closure- 15 hours @ 25 degrees C),
the embryo begins to resemble the larval body plan.  In a process known as head involution,
the cells of the head rotate 180 degrees and many of the head structures are internalized (Fig.
2E vs. F).  On the ventral epidermis, segmentation is obvious in the form of repeated patterns
of actin-rich denticles and naked cuticle (Fig. 2G, arrows).  If all goes well, the soon to hatch
embryo looks like a first instar larvae (Fig. 2G).  By examining the cuticle of this late stage
embryo in various mutant backgrounds, specific defects in morphogenesis can be identified.
For example, a dorsal hole implicates a gene’s role in dorsal closure, while a head hole would
point to a function in head involution.
11
Putting it all together
The stage is set to unravel the complex molecular machinery that rearranges the nuts
and bolts of cell and tissue shape to build an animal.  For a given candidate regulator, we
must understand how this protein interacts with the structural elements and with other
regulatory proteins.  For a given morphogenetic process, we must understand which
regulators are involved and which are dispensable.  Studies across several organisms and cell
culture models are key to verify observations in one system.  As this difficult but rewarding
work continues, we will progress from a “parts list” to an “instruction manual” for building
an animal.
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Fig. 1.1.  Composition of Adherens Junctions.  Homophilic, calcium-dependent contact
between two cells is mediated by the extracellular domain of Cadherin.  Within the cell,
Cadherin binds two catenin proteins: at the membrane proximal region, p120-catenin, and
more distal, Beta-catenin.  Beta-catenin then binds alpha-catenin, which can bind actin.
(Adapted from Peifer and Yap, 2003).
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Fig. 1.2.  Drosophila epithelial morphogenesis.  All embryos are oriented with anterior to
the left, dorsal side up (except G, ventral side facing front).  A.  Blastoderm stage embryo,
prior to morphogenesis.  B.  Gastrulating embryo.  Arrow shows site of internalizing
posterior midgut.  Black line shows approximate length in A-P axis of germband cells.  C.
Embryo at the completion of germband extension.  Black line shows the length of the
germband after cell intercalation is complete.  Segmentation is apparent, as is the
amnioserosa (C-shaped layer of white cells in middle of embryo).  D.  Embryo after
completion of germband retraction.  The amnioserosa (star) now covers the dorsal surface of
the embryo.  Arrow shows location of leading edge cells.  E.  Embryo after dorsal closure.
The amnioserosa is now enclosed.  Note the changes in head structure from D., as head
involution has begun.  F.  Embryo at the completion of epithelial morphogenesis.  Head
involution is now complete (compare with E).  G.  Cuticle preparation of a wild-type embryo,
showing internalized head structures.  On the ventral side is the repeated pattern of denticles
(black arrow) and naked cuticle (white arrow). A-F adapted from Hatenstein, 1993.
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CHAPTER 2
SUMMARY OF CONTRIBUTIONS TO PUBLISHED WORK
Preface
The following describes my contribution to two publications on which I am a co-
author.
Myster et al, 2003
This publication addressed the role of the Drosophila orthologue of p120-catenin
(p120) as an adherens junction component and regulator.  Our lab confirmed that like
mammalian p120, Drosophila p120 binds to the juxta-membrane domain of E-cadherin.
Despite reports that mammalian p120 is an essential gene, we found that flies lacking the
only p120-like protein are viable and fertile.  However, we found that p120 plays a
supporting role in adhesion, as reduction of p120 in a background of sensitized adhesion (E-
cadherin mutant) enhanced the phenotype.
My contribution to this work concerned the localization of adherens junction
components and actin in the absence of p120.  I found that the core adherens junction
components DE-Cadherin, Armadillo (Beta-catenin) and alpha-catenin localize normally in
p120 mutant embryos.  Further, I found no change in the actin cytoskeleton in the absence of
p120.
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Grevengoed et al, 2003
This publication identified a mechanistic role for Abl kinase in Drosophila.  To better
understand Abl’s mechanism of action, we examined abl maternal mutants at a simple stage
of development- the blastoderm stages.  At this stage, no cells have been formed, but nuclei
divide and are transiently separated during interphase by “pseudo-cleavage furrows.”  At the
final stage of this process, the nuclei finally form cells in a modified form of cytokinesis
known as cellularization.  We found abl mutants to exhibit defects in both pseudocleavage
furrows and at cellularization.  Ultimately, we found Abl’s regulation of apical actin
polymerization to be the cause of this phenotype, and we found that Abl regulates actin by
negatively regulating the apical localization of Enabled (Ena).
My role in this work was to analyze the role of adherens junctions during blastoderm
stages.  As work in our lab had previously found Abl to regulate adherens junctions
(Grevengoed et al, 2001), we wondered whether loss of adherens junctions gave rise to an
abl-like phenotype during blastoderm stages.  Thus, I generated maternal mutants for both
armadillo and shotgun (E-cadherin).  I found that while either mutant background disrupted
adherens junction localization (as assayed by alpha-catenin localization), pseudo-cleavage
furrow formation and cellularization occurred normally in the absence of adherens junctions.
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Preface
The following chapter describes work of myself and others regarding the role of Rho1
in adherens junction regulation.  The impetus for this work came largely from a publication
regarding the role of Rho1 and p120 at adherens junctions (Magie et al 2002).  Using RNA
interference and mis-expression techniques, this work argued for an essential role for p120
during embryonic development.  Further, the authors concluded that p120 is an essential
regulator of Rho1, and, in turn, that Rho1 is an essential regulator of adherens junctions.
Given our lab’s observation that p120 is not essential for embryonic development or
adherens junction function (Myster et al 2003), we decided that further examination was
needed to determine if p120 was an essential regulator of Rho1 function.  Therefore, we
performed the following experiments to ask whether p120 was an essential Rho1 regulator
and whether Rho1 itself behaves as a regulator of adherens junctions.  In addition to
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performing p120 RNAi and mis-expression approaches, we examined p120 loss of function.
Further, we constructed Rho1 shg double mutants to more rigorously evaluate the hypothesis
that Rho1 is an adherens junction regulator.  While I performed a majority of the
experiments, the following were done by other Peifer lab members: C. Homem analyzed the
timing of dorsal closure in p120 mutants and examined shg mutant follicle cell clones, S.
Myster generated and initiated studies of p120 Rho1 double mutants, F. Wang assisted in the
p120 RNAi analysis, and E. Bain analyzed cell shape in p120 mutants and assisted in
generating Rho1 shg double mutants.  This work was published in Development in 2005.
Summary
During animal development, adherens junctions (AJs) maintain epithelial cell
adhesion and coordinate changes in cell shape by linking the actin cytoskeletons of adjacent
cells.  Identifying AJ regulators and their mechanisms of action are key to understanding the
cellular basis of morphogenesis.  Previous studies linked both p120catenin and the small
GTPase Rho to AJ regulation and revealed that p120 may negatively regulate Rho.  Here we
examine the roles of these candidate AJ regulators during Drosophila development.  We find
that although p120 is not essential for development, it contributes to morphogenesis
efficiency, clarifying its role as a redundant AJ regulator.  Rho has a dynamic localization
pattern throughout ovarian and embryonic development.  It preferentially accumulates
basally or basolaterally in several tissues, but does not preferentially accumulate in AJs.
Further, Rho1 localization is not obviously altered by loss of p120 or by reduction of core AJ
proteins.  Genetic and cell biological tests suggest that p120 is not a major dose-sensitive
regulator of Rho1.  However, Rho1 itself appears to be a regulator of AJs.  Loss of Rho1
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results in ectopic accumulation of cytoplasmic DE-Cadherin, but ectopic cadherin does not
accumulate with its partner Armadillo.  These data suggest Rho1 regulates AJs during
morphogenesis, but this regulation is p120-independent.
Introduction
During animal development, coordinated changes in cell shape and position build the
body plan and drive morphogenesis.  These changes are executed in part by the actin
cytoskeleton, and neighboring cells act in concert by linking their cytoskeletons to cell-cell
and cell-matrix junctions (reviewed in Perez-Moreno et al., 2003).  In epithelial cells,
adherens junctions (AJs) mediate cell-cell adhesion, via interactions between cadherins on
neighboring cells.  Within the cell, the cadherin cytoplasmic tail indirectly interacts with
apical actin via β- and α-catenin (reviewed in Tepass et al., 2001).
In addition to these core AJ components, regulatory proteins modulate both AJ
stability and connections to the cytoskeleton (reviewed in Gumbiner, 2000).  Identifying how
these regulators modify AJs during development is critical to understanding morphogenesis.
Studies in cultured mammalian cells and other systems identified many candidate AJ
regulators, including the catenin p120 and the small GTPase Rho (mammalian RhoA or
Drosophila Rho1).
p120 binds the Juxta-Membrane region of cadherins (reviewed in Anastasiadis and
Reynolds, 2000).  Initially, the regulatory relationship between p120 and AJs was unclear.
Overexpression of mutant E-cadherins lacking the Juxta-Membrane domain in different
mammalian cell types gave opposing results suggesting that p120 either promotes  (Yap et
al., 1998) or downregulates adhesion (Ozawa and Kemler, 1998).   siRNA knockdown of
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p120 in mammalian cells clarified this, showing that p120 promotes AJ stability by blocking
E-cadherin endocytosis (Davis et al., 2003; Xiao et al., 2003).
In invertebrates, p120 also promotes adhesion but may be dispensable for viability. In
C.elegans, p120/jac-1 RNAi enhances the hmp-1/α-catenin phenotype, but jac-1 RNAi alone
does not disrupt morphogenesis (Pettitt et al., 2003).  Similarly, loss of p120 enhances the
phenotype of Drosophila E-Cadherin (DE-Cad) mutants but loss of p120 alone (Myster et al.,
2003) or expression of p120 RNAi transgenes (Pacquelet et al., 2003) do not affect viability
or cell adhesion.  However, injection of p120 double-stranded RNA (dsRNA) in embryos
was reported to disrupt morphogenesis (Magie et al., 2002).  This suggested that rapid
depletion of p120 might have more severe consequences than chronic depletion.
In mammalian cells p120 also may function outside of AJs (Anastasiadis and
Reynolds, 2000).  In the cytoplasm, p120 can negatively regulate RhoA.  Rho regulates many
cellular processes including actin organization, cell migration, and cell polarity (reviewed in
Etienne-Manneville and Hall, 2002).  siRNA knockdown of mammalian p120 increases
RhoA activity and promotes stress fiber formation (Shibata et al., 2004).  Conversely, p120
overexpression causes fibroblasts to lose stress fibers (Anastasiadis et al., 2000; Noren et al.,
2000) and contractility (Grosheva et al., 2001), both RhoA-dependent processes (Ridley and
Hall, 1992; Chrzanowska-Wodnicka and Burridge, 1996).
Recently, the relationship between p120 and Rho has begun to be tested in vivo, but
the results do not yield a consistent mechanistic picture.  Embryonic defects caused by
knockdown of p120 family members in Xenopus can be partially rescued by both dominant-
negative (Fang et al., 2004) and wild-type RhoA (Ciesiolka et al., 2004).  These contrasting
results are consistent with p120 activating or repressing RhoA, respectively.  In Drosophila,
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p120 preferentially binds Rho1-GDP and regulates Rho1 localization.  Overexpression of
p120 enhances Rho1’s phenotype (Magie et al., 2002), suggesting that fly p120 negatively
regulates Rho1.  Thus p120 may regulate morphogenesis by regulating AJs and/or Rho.
Additionally, Rho itself regulates AJ stability.  Blocking RhoA function in
keratinocytes prevents the formation of stable AJs (Braga et al., 1997).  In Drosophila, both
Rho1 loss-of-function and expression of dominant-negative Rho1 during embryogenesis alter
DE-Cad localization (Magie et al., 2002; Bloor and Kiehart, 2002).  However, the regulation
of AJs by Rho is likely complex, as manipulation of different RhoA effectors can promote or
decrease AJ stability in mammalian cells (Sahai and Marshall, 2002, Vaezi et al., 2002).
Additionally, AJs may regulate Rho activity, since Cadherin-Cadherin engagement can either
activate (Charrasse et al., 2002; Nelson et al., 2004) or inhibit (Noren et al., 2001; 2003)
RhoA activity in vitro.
Work in cultured cells supports roles for both p120 and Rho as AJ regulators, but the
interactions among p120, Rho, and AJs are complex.  Ultimately, we want to understand how
Rho and p120 regulate AJs during the intricate events of embryonic morphogenesis.  One
key question is whether Rho and p120 act together in this process.  Here we use Drosophila
to investigate this.
Materials and methods
RNAi
~0.7 kb of p120, ftz, or gfp coding sequence were amplified from cDNA using primers
introducing T7 promoters, and used to synthesize dsRNAs using the MEGAscript® kit
(Ambion).  For p120::GFP injections, the control dsRNA was against dysfusion (Jiang and
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Crews, 2003).  Syncytial blastoderm embryos were bleach-dechorionated, and injected under
halocarbon oil at the posterior end with dsRNA at 5µM.  For hatch rate estimates, injected
yellow white embryos were left 3 days at 18°, and unhatched embryos collected for cuticle
preparations.  Injected p120::GFP embryos were aged 24 hours at 18° and transferred to
petriPERM plates (Sartorius Corp.) for imaging.
Fly Stocks
Mutations are described at flybase.indiana.edu.  Rho1rev220 and Rho11B (Magie et al., 2002;
2005) were from S. Parkhurst (Fred Hutchison).  Homozygous Rho1 mutants were identified
using a Kr::gfp balancer (Casso et al., 1999);  controls were Kr::gfp positive siblings.  For
Rho1 localization in p120, histone::gfp was the control.  Otherwise it was yellow white.
Recombinant genotypes were confirmed by failure to complement an independently-derived
allele; p120308 was confirmed by PCR.  Cuticle preparations were as in Wieschaus and
Nüsslein-Volhard (1986).  Unless noted, experiments were done at 25°C.  Live imaging
utilized wild-type or p120308 mutants expressing moesin::GFP.  Follicle cell clones: heat-
shock-FLP/+; FRT42DshgR69/FRT42D gfp females were heat-shocked one hour at 37°C for
two consecutive days before dissection.
Immunofluorescence
Ovaries were treated as in Magie et al. (2002).  Embryos were fixed in 1:1 PBS+3.7%
formaldehyde:heptane for 20 min, except for Rho1 staining, which was as in Padash-Barmchi
et al. (2005).  Embryos were methanol-devitellinized (or hand-devitellenized for phalloidin),
blocked and stained in PBS/1% goat serum/0.1%Triton-X-100. Antibodies: anti-Rho1p1D9
(1:50), anti-βPS1 integrin (1:3), anti DE-Cad2 (1:200), anti-ArmN2 (1:200; all
Developmental Studies Hybridoma Bank), anti-DRhoGEF2 (1:500, Rogers et al., 2004), anti-
29
phosphotyrosine (1:1000, Upstate Biotechnology).  Alexa®-phalloidin was used at 1:1000;
secondary antibodies were Alexas® 488, 568, and 647 (Molecular Probes).  Embryos were
mounted in Aqua-Polymount (Polysciences).  Fixed samples were imaged using a Zeiss
LSM510 confocal microscope and LSM software.  Live imaging used a Perkin-Elmer
Ultraview spinning-disc confocal, an ORCA-ER digital camera (Hamamatsu), and
Metamorph software. To analyze dorsal closure timing, we began analysis of all movies
when the maximum separation between the leading edges was 52 microns (as measured in
Metamorph), and ended analysis when the leading edges met along their entire length.  All
images were acquired at 40X.  Adobe Photoshop7.0® was used to adjust brightness and
contrast.  When comparing wild-type and mutants, images were adjusted identically.
Results
p120 RNAi is not lethal
Our previous genetic analysis suggested that p120 is not essential for Drosophila
development, but plays an important positive-modulatory role in cell adhesion that is
revealed by reducing levels of DE-Cad (Myster et al., 2003).  However, Magie et al. (2002)
suggested that embryos suddenly deprived of p120 have developmental defects.  We tested
this by injecting blastoderm-stage embryos with dsRNA directed against the p120 coding
region.  p120 RNAi does not result in embryonic lethality (68.8% of embryos hatch versus
63.5% of embryos injected with a negative-control (gfp) dsRNA; Table 1), while RNAi of
the essential gene ftz results in embryonic lethality (Table 1).  Since about one–third of both
p120-dsRNA and gfp-dsRNA injected embryos died, we suspected this residual lethality
resulted from injection-associated defects.  Consistent with this, p120 and gfp RNAi gave
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similarly variable distributions of cuticle defects (Table 1), while 90% of ftz RNAi embryos
displayed the characteristic loss of every other body segment (Wakimoto et al., 1984).  To
rule out the possibility that we failed to knockdown p120 protein, we injected embryos
expressing GFP-tagged p120 (Myster et al., 2003), using the same preparation of p120
dsRNA.  >80% of p120 dsRNA-injected p120::GFP embryos lost detectable junctional
p120::GFP (Table 2. Fig. 1B; Fig. 9), whereas >80% of p120::GFP embryos injected with
control dsRNA retained junctional p120::GFP (Table 2; Fig. 1A; Fig. 9).  Thus RNAi of
Drosophila p120, like p120 loss-of-function mutations, is not lethal.
Loss of p120 slows but does not disrupt dorsal closure
p120 mutants are viable and fertile, and AJ proteins and actin accumulate normally
in p120 mutant embryos (Myster et al., 2003).  We noted, in passing, that a fraction of p120
mutants exhibit slight defects in cell shape during dorsal closure, a process during which
lateral sheets of epithelial cells elongate and migrate dorsally, enclosing the embryo in
epidermis.  To examine whether p120 plays a subtle role in morphogenesis, we looked in
detail at dorsal closure, examining cell shape changes and cell behavior in fixed and live
p120 mutants.  We examined each stage in dorsal closure and observed no consistent
differences between p120 mutants and wild-type (Fig. 1C-J).  F-actin localization was also
similar (Fig. 1 K vs. L).
We next examined whether more subtle changes on cell behavior were revealed by
imaging dorsal closure in living embryos expressing a GFP-tagged F-actin-binding fragment
of Moesin that highlights the cytoskeleton (Moesin::GFP; Edwards et al., 1997).   Once
again, we saw no gross defects in cell shape in p120 mutants.  However, loss of p120 slows
the rate of dorsal closure.  On average, wild-type embryos complete dorsal closure within 75
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minutes (Fig. 1O).  p120 mutants are significantly slower, taking 112 minutes (Fig. 1O).
Despite this, p120 mutants complete dorsal closure without apparent defects.  Thus, loss of
p120, while not lethal, alters the efficiency of morphogenesis.
Rho1 exhibits dynamic localization
In mammalian cells, p120 regulates Rho activity.  One mechanism to regulate Rho is
by controlling its subcellular localization.  Previous workers examined Rho1 localization in
both ovaries and embryos (Magie et al., 2002; Padash-Barmchi et al., 2005).  Drosophila
Rho1 was reported to localize to AJs (Magie et al., 2002), suggesting that this might be a
mechanism by which it both regulates and is regulated by AJs.  We re-examined Rho1
localization compared to that of AJs.  This revealed new information about Rho1dynamic
localization, sometimes confirming previous work and in other cases contradicting it.
We began with oogenesis (utilizing the same protocol and anti-Rho1 monoclonal
antibody used in Magie et al, 2002). Ovarian follicle cells form an epithelium with its apical
surface inward, providing an excellent place to examine AJs.  After egg chambers form,
Rho1 localizes to follicle cell apical and lateral membranes (Fig. 2A, white arrowhead), and
along lateral membranes of stalk cells (Fig. 2A, red arrowhead).  Rho1 remains enriched at
follicle cell lateral membranes (Fig. 2F,H), but apical enrichment decreases at later stages
(Fig. 2H).  DE-Cad is strongly enriched in apical AJs (Fig. 2C,F,H blue arrowheads).  Rho1
localization sometimes overlaps DE-Cad at AJs, but it is not enriched there (Fig. 2C,F,H).  In
grazing sections at stage 10, Rho1 accumulates in puncta where three follicle cells meet (Fig.
2E arrows, J); these puncta are basal to the strongest DE-Cad staining (data not shown) and
do not co-localize with DE-Cad (Fig. 2E).   Thus Rho1 is not enriched in AJs of most follicle
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cells.  However, like AJ proteins (Peifer et al., 1993; Oda et al., 1997), Rho1 does
accumulate at germ cell boundaries (Magie et al., 2002; Fig. 2B arrowhead).
Posterior polar follicle cells preferentially accumulate AJ proteins (Peifer et al., 1993;
Niewiadomska et al., 1999; Fig. 2C, arrow).   In contrast, Rho1 levels in these cells resemble
those of their neighbors (Fig. 2C, arrow).  Border cells also accumulate elevated levels of AJ
proteins (Oda et al., 1997; Niewiadomska et al., 1999) and require DE-Cad to migrate to the
anterior end of the oocyte.  During migration, border cells accumulate Rho1 (Magie et al.,
2002; Fig. 2L) at both the plasma membrane and in cytoplasmic puncta (Fig. 2M
arrowheads).  These may represent multivesicular bodies that are enriched in border cells
(Peifer et al., 1993).  DE-Cad is enriched in apical AJs of centripetal follicle cells that
migrate between nurse cells and the oocyte (Fig. 2D; red arrowhead).  Rho1 accumulates
with DE-Cad in these cells apically (Fig. 2D; red arrowhead); Rho1 is also enriched in more
basal puncta (Fig. 2D; blue arrowhead).  Thus in the ovary, while Rho1 and DE-Cad overlap
in some places, Rho1 does not preferentially localize to AJs.
We also compared Rho1 and DE-Cad localization in embryos, extending earlier work
(Magie et al., 2002; Padash-Barmchi et al., 2005; the pictures presented use the protocol of
Padashi-Barchi (2005), but similar results were also seen with the protocol of Magie et al.
(2002)).  Rho1 localization is very dynamic.  During cellularization, Rho1 is enriched at
invaginating furrow canals (Fig. 3A, blue arrowhead), as previously observed (Padash-
Barmchi et al., 2005), while DE-Cad localizes both to basal (Fig. 3A, yellow arrowhead) and
developing apical AJs (Fig. 3A, white arrowhead).  At gastrulation, DE-Cad is enriched in
AJs of posterior midgut cells (Fig. 3E, blue arrowhead), while Rho1 accumulates in basal
puncta (Fig. 3D,E white arrowheads) that may be furrow canal remnants.  DE-Cad is also
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enriched in apical AJs of invaginating cells in the ventral furrow, while Rho1 is only weakly
enriched in the ventral furrow (Fig. 3F, arrowheads).  After mesodermal cells invaginate,
they accumulate cortical Rho1 (Fig. 3H, yellow arrowheads).  In epithelial cells, we observed
two general features of Rho1 localization.  In several cell types, Rho1 localized basally.
After germband extension, Rho1 accumulates basally where ectoderm meets mesoderm (Fig.
3G,H arrowheads).  ßPS1-integrin also localizes there (Fig. 3I, arrowheads).  Later, Rho1
localizes basally in the hindgut epithelium (Fig. 3M, blue arrowheads; DE-Cad accumulates
apically).  Second, comparison of blastoderm, extended-germband, and dorsal closure-stage
embryos shows that cortical enrichment of Rho1 decreases over time (Fig. 3J-L).  Thus Rho1
localization varies in different cell types, but it is not significantly enriched in AJs of most
cells.
Rho1 zygotic mutants have defects during dorsal closure (Magie et al., 1999).  We
thus closely examined Rho1 localization at that stage, collecting sections in the Z-axis
through the lateral epithelia.  Apically, Rho1 does not localize to AJs but accumulates at low
levels in the cytoplasm (Fig. 4A,A’).  Basal to AJs (where DE-Cad is seen at AJs of
invaginating segmental groove cells; Fig. 4B,B’), Rho1 levels increase and it is more
cortical.  Thus in these cells Rho1 is enriched basal to AJs.  Another important input in Rho1
regulation is localized activation by RhoGEFs.  While a comprehensive study is beyond the
scope of our work, we examined RhoGEF2 during dorsal closure, which colocalizes with
Rho1 during cellularization (Padash Barmchi et al., 2005).  During dorsal closure, RhoGEF2
accumulates basal to AJs (Fig. 4H-H’), like Rho1.  However, RhoGEF2 is more cortical,
poising it to activate a cortical pool of Rho1.  Thus, during oogenesis and embryogenesis
Rho1 localization varies among different cell types, with basal or basolateral accumulation in
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many epithelia. Importantly, we found no evidence for preferential Rho1 accumulation at
AJs, although the localizations do sometimes overlap.
Rho1 localization is independent of p120 and core AJ protein function.
Both p120 and α-catenin can bind Rho1 (Magie et al., 2002).  These authors reported
that RNAi of either p120 or α-catenin altered Rho1 localization.  While we did not observe
strong enrichment of Rho1 at AJs, it remained possible that p120 or core AJ proteins could
regulate Rho1 localization.  To examine this, we first examined p120 null mutant ovaries and
embryos.  As previously observed in embryos (Myster et al., 2003), p120 mutant follicle cells
exhibit normal DE-Cad localization to AJs (Fig. 2G,I).  In p120 mutant follicle cells, Rho1
localization to the cytoplasm, the lateral membrane (Fig. 2F vs. G, H vs. I) and its
accumulation in puncta in late-stage follicle cells (Fig. 2J vs. K) were indistinguishable from
wild-type.  We also saw no change in Rho1 localization in p120 mutant embryos; e.g., Rho1
localization to furrow canals (Fig. 3B vs. C) and its basal localization in the hindgut (Fig. 3M
vs. N) are unchanged.  Further, there were no changes in apical (Fig. 4C’ vs. A’) or
basolateral (data not shown) Rho1 localization during dorsal closure in p120 mutants.  In
particular, we did not observe elevated Rho1 accumulation at the leading edge, as was
previously reported for p120 RNAi (Magie et al., 2002).  Thus p120 is not required for
normal Rho1 localization in ovarian or embryonic epithelia.
We next examined whether core AJ proteins are critical for Rho1 localization. We
addressed this in the follicle cell epithelium by generating homozygous null DE-Cad
(shotgun;shgR69) mutant clones (marked by loss of GFP; Fig. 4I-M’’).  DN-Cadherin can act
in place of DE-Cad (Tanentzapf et al., 2000) during early oogenesis; thus in early stage egg
chambers Arm remains at AJs despite loss of DE-Cad (Fig. 4I).  However, by stage 10 this
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redundancy is less apparent; loss of DE-Cad substantially reduces Arm accumulation in AJs
(Fig. 4J-K’’).  We thus confined our analysis to late stages. Rho1 localization is unchanged in
shg null mutant follicle cells (Fig. 4L,M).  We also examined Rho1 localization in embryos
zygotically mutant for core AJ proteins.  In zygotic arm null mutants, DE-Cad is no longer
detectable by dorsal closure (data not shown).  Zygotic shg null mutants lose DE-Cad from
the epidermis, though some maternal DE-Cad remains in the aminoserosa (Fig. 4G’).  In both
arm (Fig. 4E vs. F) and shg (Fig. 4G) zygotic mutants, Rho1 localization is unchanged.
Thus core AJ components do not play a major role in Rho1 localization in Drosophila
epithelia.
Drosophila p120 is not a key regulator of Rho1 function.
While p120 is not essential for Rho1 localization, it might regulate Rho1 function by
other mechanisms.  Often regulators, even those that are partially-redundant, can be
identified by looking for phenotypic effects in a sensitized genetic background.   For
example, p120’s supporting role in AJs was revealed by the fact that loss of p120 strongly
enhances DE-Cad mutants (Myster et al., 2003).  In zygotic Rho1 mutants, maternal Rho1 is
gradually depleted, and thus we reasoned that altering a Rho1 regulator might modify the
consequences of reduced levels of Rho1.
To test whether p120 and Rho1 genetically interact, we generated p120 Rho1 double
mutants and compared their phenotypes to those of Rho1.  Rho1 mutant embryos had the
defects described previously (Magie et al., 1999; unless noted, we used the strong allele
Rho1rev220).  Most embryos lack head cuticle; the remaining cuticle differs significantly in
size among different embryos (Fig. 5 and Table 3), perhaps due to the varying degrees of
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“bowing” of the dorsal surface previously observed (Magie et al., 1999).  p120 null mutants
(p120308, used for all experiments) have normal cuticles and are embryonic viable.
Complete removal of p120 does not substantially modify the Rho1 phenotype, nor
was a novel double-mutant phenotype seen.  The percentage of embryos with head holes was
quite similar, for example (76.1% of Rho1 mutants versus 74.6% of p120 Rho1 double
mutants; Table 3).  We did observe an effect on one aspect of the phenotype: p120 Rho1
double-mutants had twice as many long cuticles than Rho1 single mutants (Table 3; Fig. 5;
this was seen in two separate experiments).  This phenotypic shift may reflect subtle
suppression of Rho1 by p120.  However, this is much more subtle than the effect of p120 loss
on the shg phenotype (Myster et al., 2003), and may simply reflect differences in genetic
background or sample preparation—we observed comparable variation between different
cuticle preparations of the same genotype (data not shown).
As a second test for genetic interactions, we examined whether p120 over-expression
modifies the Rho1 phenotype, ubiquitously expressing a p120 transgene under the control of
the GAL4-UAS system (Myster et al., 2003; using actin-GAL4).  Magie et al. (2002)
previously reported that p120 over-expression using actin-GAL4 enhanced the Rho1
phenotype.  However, using an independently-derived UAS-p120 transgene, we did not
observe phenotypic enhancement.  Instead, our results suggest a slight suppression of the
Rho1 phenotype.  The overall range of phenotypes was similar, with a small shift toward the
less severe categories (Table 3; data not shown).  However, this effect was fairly small, and
may reflect differences in genetic background.
We also compared the effect of loss of Rho1 with the loss of both Rho1 and p120 on
F-actin during dorsal closure.  As previously observed by Magie et al. (1999), Rho1 mutants
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are nearly normal during early dorsal closure (Fig. 5J vs. K), with defects becoming apparent
during late dorsal closure.  The Rho1 phenotype is variable-- in more severely affected Rho1
mutants both the leading-edge actin cable and cell shape changes are less uniform (Fig. 5M
vs. N).  In less severely affected mutants, when leading edges meet at the dorsal midline the
two epithelial sheets do not line up or intercalate normally (Magie et al., 1999; Fig. 5P vs. Q).
p120 Rho1 double mutants exhibited the same range of phenotypes as Rho1 single mutants
during early (Fig. 5K vs. L) and later stages of dorsal closure (Fig. 5N vs. O, Q vs. R).  Thus,
p120 does not behave genetically as a key regulator of Rho1 function, contrasting with its
strong genetic interactions with DE-Cad (Myster et al., 2003).
Rho1 and shg genetically interact.
These data suggest that p120 is not a required regulator of Rho function in
Drosophila.  However, there are other strong links between Rho and AJs-- evidence from
mammalian cell culture and Drosophila strongly suggest that Rho regulates AJ protein
localization and function.  To probe the relationship between Rho and AJs during embryonic
morphogenesis, we asked whether Rho1 genetically interacts with DE-Cad (shg) by
constructing double mutants for Rho1 and each of three shg alleles: a weak allele, shgG119
(Tepass et al., 1996), a strong allele, shg2 (Uemura et al., 1996=shgIH81, Nüsslein-Volhard et
al. 1984), and a protein-null allele, shgR69 (Godt and Tepass, 1998).  Embryonic epithelia
have differential sensitivity to DE-Cad loss (Tepass et al., 1996).  The head epidermis, which
undergoes extensive rearrangements, is most sensitive.  Thus, weak alleles like shgG119
mainly disrupt head cuticle (Fig. 6, Table 4).  The next most sensitive tissue is the ventral
epidermis, site of neuroblast delamination.  Strong shg alleles like shg2 disrupt head and, to
varying degrees, ventral epidermis (Fig. 7, Table 5).  Finally, null shg alleles like shgR69 lack
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head, ventral, and to some extent, dorsal cuticle (Fig. 7, Table 5).  We reasoned that novel
phenotypes in double mutants or suppression of one mutation by another might indicate a
genetic interaction.
Loss of Rho1 enhances the phenotype of the weak allele shgG119 (Fig. 6, Table 4).
Most double mutant embryos have holes in their ventral epidermis that are not present in
most shgG119 single mutants.  Since both Rho1 and shgG119 affect head involution, the
enhancement of this phenotype may simply reflect additive effects.  However, since loss of
Rho1 does not affect integrity of the ventral epidermis, we believe enhancement of this
aspect of the phenotype is likely to reflect a genetic interaction.  We also assessed whether
reduction of the dose of Rho1 had an effect on the shgG119 phenotype—there was no apparent
effect of reducing the maternal and zygotic Rho1 dose by half.  Surprisingly, however, Rho1
does not enhance, but instead partially suppresses, the phenotype of stronger shg alleles (Fig.
7, Table 5).  For both alleles, a larger fraction of double mutant progeny fall into less severe
phenotypic categories. Thus, Rho1 behaves genetically as a regulator of AJ function, but the
nature of this genetic interaction is complex.
We also sequenced the two non-null shg alleles.  shgG119 has an in-frame deletion of
four conserved amino acids in the membrane-proximal lamininG domain in the extracellular
domain (Fig 6D).  shg2 has two mutations:  missense changes in a conserved amino acid in
the lamininG domain and in a conserved residue in the cytoplasmic tail (Fig. 6D, 7G) at the
C-terminal end of the Arm-binding site (Pai et al. 1996; Huber and Weis, 2001; Pokutta and
Weis, 2000).
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Rho1 regulates DE-Cad but not Arm localization
Rho1 was reported to be required for correct localization of AJ proteins (Magie et al.,
2002; Bloor and Kiehart, 2002).   We examined embryos lacking zygotic Rho1.  During
dorsal closure, DE-Cad accumulated ectopically, as previously reported (Magie et al., 2002).
Ectopic DE-Cad accumulates in the cytoplasm of epithelial or amnioserosal cells near the
leading edge (Fig. 8A vs. B).  Ectopic DE-Cad also accumulates in Rho1 embryos prior to
(Fig. 8C vs. D) and following dorsal closure (Fig. 8E vs. F).  Importantly, however, ectopic
DE-Cad did not colocalize with its binding partner Arm (Fig. 8B).   Finally, we used the
ectopic DE-Cad phenotype of Rho1 mutants to further test whether p120 regulates Rho1.
p120 Rho1 double mutants accumulate ectopic DE-Cad during dorsal closure in a fashion
identical to Rho1 single mutants (Fig. 8G vs. B).  Thus, Rho1 regulates DE-Cad but not Arm
localization and the effect of loss of Rho1 is not enhanced or suppressed by removing p120.
Discussion
The regulation of adhesion and its coupling to the actin cytoskeleton are critical for
morphogenesis.  Rho and p120 both regulate adhesion and the cytoskeleton, but the precise
nature of their roles and the interrelationship among them are less clear.  We addressed these
issues during development in Drosophila.
Drosophila p120: a redundant regulator of AJs
In mammalian cells, p120 is a key regulator of cadherin-based adhesion (Davis et al.,
2003; Xiao et al., 2003).  However, the universality of this role was called into question by
the viability of p120 mutant flies (Myster et al., 2003).  One caveat remained, however.
Magie et al. (2002) reported that rapidly depleting fly embryos of p120 by RNAi led to
defects in morphogenesis and Rho1 localization.  To resolve this discrepancy, we carried out
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p120 RNAi.  Our data confirm that knockdown of p120 does not result in lethality.  Thus,
Drosophila (these data; Myster et al., 2003; Pacquelet et al., 2003) and C. elegans p120
(Pettitt et al., 2003) are dispensable for development.  In contrast, p120 knockdown in
Xenopus or M. musculus is lethal (Fang et al., 2004; Al Reynolds, pers. comm.), suggesting
differences in p120’s importance in vertebrates versus invertebrates.
Since Drosophila has a single p120 family member, simple redundancy does not
explain the difference.  We imagine two possible explanations.  First, p120 proteins may play
fundamentally different roles in vertebrates and invertebrates.  Alternately, p120’s role in
both may be similar, but the relative importance of p120 and unrelated, partially-redundant
regulators of cadherin and/or Rho may differ.  We favor the latter possibility, since p120
binds to and promotes the function of AJs in vertebrates and invertebrates (Anastasiadis and
Reynolds, 2000; Myster et al., 2003; Pettitt et al., 2003), and p120 has a conserved role in
regulating morphogenesis, contributing to dorsal closure efficiency (these data) and
regulating dendrite morphology (Li et al. 2005) in Drosophila and regulating gastrulation and
craniofacial morphogenesis in Xenopus (Fang et al., 2004; Ciesiolka et al., 2004).  One role
of p120 is to inhibit cadherin endocytosis.  Perhaps in invertebrates other regulators of
cadherin trafficking compensate for its absence.
Drosophila p120: a redundant regulator of Rho1?
The second postulated role for p120 is as a Rho regulator.  The viability of p120 mutants
suggested that Drosophila p120 is not an essential Rho1 regulator.  However, this did not
rule out a role as one of several Rho1 regulators with overlapping functions.  For example,
Magie et al. (2002) suggested overlapping roles for p120 and α-catenin, with p120 regulating
Rho1 localization during dorsal closure.  We thus looked for dose-sensitive genetic
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interactions between p120 and Rho1.  Loss of p120 does not substantially affect Rho1
function, as assessed by cuticle phenotype.  Further, loss of p120 does not enhance or
suppress the effect of Rho1 on F-actin or DE-Cad localization during dorsal closure.  p120
over-expression had only a slight effect on the Rho1 phenotype, a result that may reflect
variation in genetic background.  Thus, although Drosophila p120 preferentially binds
inactive Rho1 (Magie et al., 2002), it is not a major dose-sensitive regulator of Rho1.
We also tested the hypothesis that p120 regulates Rho1 localization, examining several
places where Rho1 exhibits striking subcellular localization, and examining the place where
Rho1 exhibits its zygotic phenotype—the dorsal closure front.  We saw no change in Rho
localization in p120 mutants.  Therefore, if p120 regulates Rho1 localization, it must do so
redundantly with other putative Rho1 regulators, such as α-catenin (Magie et al., 2002).
These data do not rule out the possibility that p120 recruits a pool of active Rho1, which may
be only a small fraction of total cellular Rho1.
p120 appears to regulate RhoA during Xenopus development (Fang et al., 2004;
Ciesiolka et al., 2004).  Perhaps redundant Rho regulators act in parallel to p120 in flies.
Alternatively, p120’s role as a Rho regulator may not be conserved—p120’s N-terminal
domain, which is implicated in regulating transitions between its adhesive and cytoplasmic
roles, is not well conserved between mammalian and fly p120.  Since p120 (Myster et al.,
2003) and Rho1 (Fig. 5) mutations modify shg mutant phenotypes differently, p120 and
Rho1 may act in separate pathways to regulate AJs in Drosophila.
Rho1 localization and its regulation
We extended previous analyses of Rho1 localization (Magie et al., 2002; Padash-
Barmchi et al., 2005).  It is dynamic, with Rho1 accumulating at different subcellular sites in
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distinct cell types, some consistent with proposed Rho functions.  For example, mammalian
RhoA regulates integrin-based cell-matrix junctions (reviewed in Burridge and Wennerberg,
2004.).  Rho1’s basal localization raises the possibility that it may regulate integrins in
Drosophila.  Rho1 accumulation in mesodermal cells is consistent with its role in regulating
cell shape during mesoderm spreading (Wilson et al., 2005).  Relative levels of cortical Rho1
decrease through development.  Perhaps at later stages Rho1 is activated by localized
RhoGEFs.  Consistent with this, RhoGEF2 is more cortically enriched during dorsal closure
than Rho1.  Thus, future studies will need to examine the localization of Rho1 regulators and
effectors.  Recent advances also allow visualization of active Rho GTPases (e.g., Benink and
Bement, 2005).  As much of the Rho1 pool may be inactive, application of this approach to
flies will advance our understanding of Rho1 function.
It was previously proposed that Rho1 is enriched at Drosophila AJs and that this is
regulated by core AJ proteins (Magie et al., 2002).  We examined this in follicle cells and
embryos.  In follicle cells, Rho1 localizes to lateral and apical membranes in early egg
chambers, and to lateral membranes later.   In neither case did we observe enrichment in AJs,
although Rho1 is not excluded from them.  In embryonic epithelia, Rho1 sometimes
localized uniformly to the basolateral membrane while in other places it was enriched
basally.  During dorsal closure, when Rho1 exhibits its zygotic phenotype, Rho1 accumulates
basal to AJs.  The lack of preferential Rho1 localization at AJs does not rule out
accumulation of a pool of active Rho1 at AJs- this will require reagents to measure Rho1
activation in vivo.  We also tested the hypothesis that AJs regulate Rho1 localization.  In
follicle cells mutant for DE-Cad and embryos mutant for arm or DE-Cad during dorsal
closure, Rho1 localization was not obviously disturbed.
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Rho is an important regulator of AJs during embryonic morphogenesis
In cultured cells, Rho and AJs have a complex relationship.  Rho regulates AJ
stability and conversely AJs regulate Rho activity (reviewed in Yap and Kovacs, 2003).
Further, different Rho effectors can promote or decrease AJ stability in cultured mammalian
cells (Sahai and Marshall, 2002, Vaezi et al., 2002).  We examined this complex relationship
during morphogenesis, using genetic and cell biological assays.  Our data support the
hypothesis that Rho1 is an important regulator of cadherin-based adhesion during embryonic
development.
Loss of Rho1 leads to DE-Cad mislocalization (Magie et al., 2002), while dominant-
negative Rho1 reduces DE-Cad in AJs (Bloor and Kiehart, 2002), implicating Rho1 in
regulating DE-Cad localization.  Our results support this hypothesis.  Cytoplasmic DE-Cad
accumulation is consistent with a role for Rho1 in regulating either DE-Cad transport to or
recycling from AJs.  We observed that the ectopic DE-Cad in Rho1 mutants accumulates
independently of its binding partner Arm.  In mammalian cells, newly-synthesized E-
cadherin must bind β-Catenin before it can be transported to AJs (Chen et al., 1999), while
endocytosed E-cadherin accumulates with either no (Xiao et al., 2003) or reduced (Le et al.,
1999) amounts of β-Catenin.  Thus our data are more consistent with ectopic DE-Cad
accumulating after endocytosis.  Consistent with this, mammalian RhoA regulates clathrin-
mediated endocytosis (Lamaze et al., 1996), and Drosophila Rho1 regulates endocytosis of
the ligand Wingless (Magie et al., 2005).  Further, constitutively-active Rac1, which can
inhibit RhoA (Sander et al., 1999), triggers E-cadherin recruitment to intracellular vesicles in
keratinocytes (Akhtar and Hotchin, 2001).  Since high levels of Rho1 do not accumulate at
AJs, either a small pool of active Rho1 at AJs is sufficient to inhibit cadherin endocytosis or
the effect is more indirect, with Rho1 acting on the actin cytoskeleton or regulators of
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endocytic trafficking.  The mechanism by which Rho1 regulates DE-Cad trafficking is an
interesting question for future studies.
Mammalian p120 also regulates cadherin endocytosis (Davis et al., 2003; Xiao et al.,
2003).  The viability of fly p120 mutants suggests that in flies this role is not rate limiting,
though the enhancement of mutants with reduced DE-Cad by p120 is consistent with p120
playing a similar role (Myster et al. 2003).  p120 and Rho could regulate DE-cad trafficking
via the same or distinct pathways.  The effect on DE-Cad trafficking in zygotic Rho1
mutants, which should have limiting levels of maternal Rho1, is not enhanced by removing
p120.  This is more consistent with a model in which the two proteins work in different
pathways, and in which p120 acts partially redundantly with another unknown regulator.
Our analysis of Rho1 and Rho1 shg mutants is consistent with the hypothesis that
Rho1 regulates AJs, but suggests that their interactions are complex.  A weak shg allele was
enhanced but stronger alleles were suppressed.  There are several possible explanations for
these contrasting results.  Weak alleles (e.g. shgG119) make protein with reduced but residual
function.  If Rho1 negatively-regulates cadherin endocytosis, more mutant DE-Cad protein
might be endocytosed in Rho1’s absence, further reducing functional DE-Cad and enhancing
the phenotype.  However, null or very strong shg alleles accumulate no functional DE-Cad at
AJs (for shg2 see Uemura et al. 1996), rendering regulation of cadherin endocytosis moot.
The slight suppression by Rho1 of strong shg alleles may result from a reduction of
morphogenetic movements, reducing cuticle disruption (as in Tepass et al., 1996).
Alternately, some mutant DE-Cad proteins may be capable of coupling to Rho1 while others
are not.  Rho1 can bind α-catenin (Magie et al., 2002), and active Rho1 may be recruited to
AJs by that interaction.  shgG119 has a wild-type cytoplasmic domain and could presumably
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couple to Rho1; reducing Rho1 might further impair its function.  In contrast, the shg2
mutation may impair Arm and/or α-catenin binding and thus Rho1 recruitment; if so this
mutant protein wouldn’t be further impaired by Rho1 removal.  Finally, the complex genetic
interactions might reflect different requirements for Rho1 during neuroblast delamination and
head involution, which are affected by strong or weak reduction in DE-Cad function,
respectively (Tepass et al., 1996). Future studies of Rho regulation of and by AJs will help
distinguish between these possibilities.
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Fig. 3.1.  Loss of p120 slows but does not disrupt dorsal closure.  Embryos.  Unless noted, in
all figures anterior is left.   (A,B)  p120 RNAi depletes p120:GFP.  GFP fluorescence,
p120::GFP embryos injected with control dsRNA (A) or p120 dsRNA (B). (C-J) Anti-
phosphotyrosine. (K,L). Phalloidin.  Wild-type (C,E,G,I,K).  p120 null mutants (D,F,H,J,L).
(M-N)  Stills, movies of representative wild-type (M) and p120 null mutants (N), both
expressing moesin-GFP.  Times, lower left.  (O).  Mean time to complete dorsal
closure±standard deviation.  Scale bars=25 µm.
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Fig. 3.2.   Rho1 localization during oogenesis.  Egg chambers.  Rho1 (red).  DE-Cad (green).
(A) Cross-section, stage 2-3.  Rho1 accumulates laterally in follicle cells (white arrowhead)
and stalk cells (red arrowhead).  (B) Stage 10.  Rho1 at germ cell boundaries (arrowhead).
(C) DE-Cad at apical AJs of follicle cells (blue arrowhead) and in polar follicle cells (white
arrow).  Rho1 does not preferentially accumulate either place. (D) Cross section, stage 10B.
DE-Cad and Rho1 elevated apically in centripetal follicle cells (red arrowhead). Rho1
accumulates basolaterally (blue arrowhead).  (E) Grazing section basal to AJs, stage 10B
follicle cells. DE-Cad is absent from tricellular junctions where Rho1 accumulates (arrows).
(F-I’’)  Cross sections, stage 5 (F,G) and 10B (H,I). Wild-type (F,H).  p120 mutants (G,I).  In
both Rho1 is enriched along lateral membranes.  DE-Cad is enriched at apical AJs
(arrowheads).  (J,K) Grazing sections, stage 10B.  Rho1 at tricellular junctions.  Wild-type
(J).  p120 (K).  (L,M) Migrating border cells.  Rho1 enriched at plasma membrane and in
intracellular vesicles (M, arrowhead).  Scale bar=white-20 µm, red-5 µm.
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Fig. 3.3.  Rho1 localization during embryogenesis.  Rho1 (red).  DE-Cad (green).  (A-C)
Cross sections, cellularization.  Wild-type (A,B).  p120 (C).  (A)  Rho1 enriched at furrow
canals (A, blue arrowhead).  DE-Cad accumulates at basal junctions (A, yellow arrowhead)
and apical AJs (A, white arrowhead).  (B,C) Loss of p120 (C) does not alter Rho1
localization.  (D-E)  Cross-section, posterior midgut (E=close-up).  Rho1 in basal puncta in
invaginating midgut cells (arrowhead).  DE-Cad (green, E) at sites of apical constriction.  (F)
Ventral furrow. DE-Cad accumulates at AJs of apically-constricting cells (arrowheads) while
Rho1 does not.  (G-I)  Cross sections, stage 8.  Rho1 accumulates where ectodermal and
mesodermal cells meet (G,H, arrowheads).  H=close-up of G.  (I) ß-PS1 integrin. (J-L)
Basolateral sections.  Stages 5 (J), 9 (K), 15 (L).  Rho1 cortical enrichment decreases.  (M-
N’’) Cross sections, stage 15 hindgut.  Wild-type (M).  p120 mutant (N).  Rho1 accumulates
basally (arrowheads).  DE-Cad accumulates in apical AJs.  Scale bars=20 µm.
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Fig. 3.4.  Neither p120 nor core AJ components are essential for Rho1 localization during
dorsal closure.  (A,B) Wild-type.  DE-Cad (A,B) versus Rho1 (A’,B’) in apical (A,A’) and
basolateral (B,B’) sections.  (A,A’) Apically, DE-Cad (A) accumulates at AJs.  Leading edge
(arrowhead).  Rho1 (A’) is at low levels in the cytoplasm and is not enriched at the leading
edge (arrowhead).  (B,B’) Basally, DE-Cad (B) accumulates at AJs in segmental grooves
(arrowhead).  Rho1 (B’) levels are higher and it is cortically enriched (arrowhead).  (C,C’)
p120 mutant. Rho1 is not elevated at the leading edge (arrowheads, C’ vs. A’).  (D,D’)
Apical RhoGEF2.  Arrowheads, leading edge.  (E-G)  Basolateral Rho1 (arrowhead) is
similar in wild-type (E), armYD35 (F), or shgR69 zygotic mutants (G). (G’) DE-Cad in a portion
of G.  (H,H’) RhoGEF2 is enriched basolaterally and is more cortical than Rho1 (H’ vs. B’)
at both amnioserosal (arrow) and epidermal cell (arrowhead) boundaries.  (I-M’’) Rho1 in
shgR69 mutant follicle cell clones.   (I-K’) GFP-green, Arm-blue, DE-Cad-red.  (I) Cross-
section, early egg chamber.  shgR69 mutant clone (bracket) indicated by lack of GFP.  Arm
accumulates at AJs at this stage despite loss of DE-Cad.  (J-K’) Cross-section (J-J’), grazing
section (K-K’), later egg chamber.  shgR69 mutant clone (bracket).  Arm and DE-Cad are
severely reduced.  (L-M’’) Grazing section, similar stage egg chamber as J, K.  GFP-green.
Rho1-blue.  DE-Cad-red.  (L) Rho1 accumulates normally in shgR69 clone.  (M-M’’)  Closeup
of L.  Scale bars=white-20 µm, red-50 µm.
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Fig. 3.5.  p120 loss-of-function does not substantially enhance or suppress Rho1. (A-I)
Cuticle preparations, anterior up.  Rho1 (A-D), wild-type (E), or p120 Rho1 (F-I).  Embryos
were divided into phenotypic classes of increasing severity (Table 3).  The percentage of
embryos in each class is listed below a representative cuticle.  Scale bar=25 µm.  (J-R) F-
actin (Phalloidin).  Wild-type (J,M,P).  Rho1 (K,N,Q).  p120 Rho1 (L,O,R).  (J-L) Lateral
view.  Early dorsal closure.  (M-R)  Dorsal views.  (M-O)  Late dorsal closure.  (P-R) After
closure.  Scale bar=20 µm.
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Fig. 3.6. Rho1 enhances a weak shg allele.  Cuticle preparations, anterior up. (A) Wild-type.
(B) shgG119.  Note head hole and small ventral scar.  (C) Rho1 shgG119.  Note head and ventral
holes. (D) Schematic of shgG119 and shg2 lesions, and sequence alignment of relevant region
in shgG119.  Gbl-cad=Gryllus bimaculatus (cricket) DE-cad homolog.  Scale bar=25 µm.
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Fig. 3.7. Rho1 suppresses both strong and null shg alleles. Cuticle preparations, anterior up.
Major phenotypic classes (>10% of cuticles), shg or Rho1 shg. (A-D) shg2.  Range of defects
includes ventral holes (A), fragmentary ventral cuticle (B), dorsal cuticle only (C), and dorsal
cuticle with holes (D).  (E,F) Rho1 shg2.  >80% of embryos have ventral holes (E) or
fragmentary ventral cuticle (F). (G) shg2 lesions in lamininG repeat and motif 5 of cadherin
tail.  DE-Cad versus Gbl-Cad, or mouse cadherins CAD-6 (Type II) and E-CAD (Type I).
(H-J) shgR69. Range of defects includes intact dorsal cuticle only (H), dorsal cuticle with
holes (I), or U-shaped dorsal cuticle (J).  (J-L)  Rho1 shgR69.  Range of defects includes
fragmentary ventral cuticle (K), dorsal cuticle only (L), or dorsal cuticle with holes (M).
Scale bar=25 µm.
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Fig. 3.8.  Rho1 regulates DE-Cad but not Arm localization.  (A,B) Wild-type (A) or Rho1
(B) during dorsal closure.  DE-Cad (red).  Arm (green).  Arrow-leading edge, arrowhead-
amnioserosa.  (C-F) DE-Cad in wild-type (C, E) and Rho11B (D, F).  Stage 9 (C,D; arrows-
amnioserosa).  Stage 17 (E,F; arrows-dorsal midline).  (G) p120 Rho1 double mutant during
dorsal closure.  Scale bar=20 µm.
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Fig. 3.9.  p120 RNAi depletes p120:GFP.  GFP fluorescence (left) and DIC images (right) of
p120::GFP embryos injected with either p120 dsRNA (A,C) or control dsRNA (B,D). (A,B)
Glancing section.  (C,D) Plane of focus near the embryo surface (reflection from the vitelline
membrane results in a uniform background).  Close-ups of these panels are in Fig. 1A,B.
(A,C) No GFP fluorescence was detected in the majority of p120 RNAi embryos. (B,D) The
majority of control dsRNA-injected embryos retain junctional p120::GFP.   Scale bar = 50
µm.
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Table 3.1.  p120 RNAi is not lethal
dsRNA
% embryos hatched
(n=)
p120
68.8% (655)
gfp
63.5% (388)
ftz
4.1% (393)
Unhatched embryos-
cuticle phenotypes
Wild-type
Head Defects
Segmental fusion
Tail up
Disrupted
ftz phenotype
N
35.7%
30.9%
8.3%
7.1%
17.8%
0%
84
29.5%
34.6%
10.3%
9.0%
16.7%
0%
78
0%
2.2%
0.7%
0.7%
6.0%
90.2%
134
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Table 3.2.  p120 RNAi significantly depletes p120::GFP
DsRNA p120 Control (dys)
Normal p120::GFP signal
10.0% 57.1%
Dim but junctional signal 3.3% 25.0%
Dim, cytoplasmic signal 3.3% 7.1%
No signal 83.3% 10.7%
N 30 28
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Table 3.3. Neither loss nor over-expression of p120 substantially modifies the Rho1
phenotype
Phenotype
Rho/+
x
Rho/+
p120Rho/p1
20+
 x
p120Rho/p1
20+
Rho/+
x
Rho/+
Rho/+; UASp120
x
 Rho/+; actin-
GAL4
wild-type or
mild head
defects
2.9% 5.5%
2.2% 9.8%
Severe head
defects 17.5% 15.9% 8.6% 12.3%
head hole with
remnant head
skeleton
3.4% 3.9% 5.3% 11.8%
head hole,
body >0.6
field at 20X
mag.
24.6% 43.0% 33.3% 17.1%
head hole,
body <0.6
field at 20X
mag.
51.5% 31.6% 50.6% 48.9%
least
severe
most
severe
N 1165 634 324 519
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Table 3.4.  Rho1 enhances a weak shg allele
Phenotype
Rho/Cy
x
Rho/+
shgG119/Cy
 x
shgG119/+
RhoshgG119/Cy
 x
 RhoshgG119/+
wild-type 0.8% 7.6% 0.5%
head defect/head hole 97.6% 16.8% 17.4%
scar in ventral cuticle 0% 50.6% 8.7%
ventral holes 0.4% 21.7% 54.0%
fragmentary ventral cuticle 0% 1.4% 17.4%
dorsal cuticle only 0.4% 1.8% 1.5%
dorsal cuticle with holes 0.4% 0% 0%
U-shaped dorsal cuticle 0% 0% 0%
Fragmented cuticle 0.4% 0% 0.3%
Least severe
Most severe
N 255 498 378
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Table 3.5.  Rho1 partially suppresses both a strong and a null shg allele
Phenotype
shg2/Cy
 x
shg2/+
Rhoshg2/Cy
 x
Rhoshg2/+
shgR69/Cy
 x
shgR69/+
RhoshgR69/Cy
 x
RhoshgR69/+
wild-type 4.5% 5.9% 6.6% 5.1%
head defect/head hole 1.5% 2.0% 0.8% 15.4%
scar in ventral cuticle 0% 0% 0.3% 0.7%
ventral holes 11.4% 39.9% 1.0% 4.0%
fragmentary ventral cuticle 55.0% 46.3% 6.1% 31.9%
dorsal cuticle only 13.7% 4.4% 24.8% 28.3%
dorsal cuticle with holes 10.6% 1.4% 42.2% 13.6%
U-shaped dorsal cuticle 2.2% 0% 17.3% 0.7%
fragmented cuticle 0% 0% 0.5% 0%
Least severe
Most severe
N 131 203 374 272
CHAPTER 4
ABELSON KINASE AND RHOGEF2 REGULATE APICAL ACTIN DURING
CELL CONSTRICTION IN DROSOPHILA
Donald T. Fox and Mark Peifer
Preface
The following chapter contains my work on the role of Abl kinase during epithelial
morphogenesis.  The goal of this work was to extend the model of Abl function, involving
regulation of apical actin via Ena (Grevengoed et al, 2003), from the blastoderm stages to
morphogenesis.  In a survey of developmental stages, I found a consistent defect on the
ventral epidermis during gastrulation in abl mutants.  This led me to characterize ventral
furrow formation, a morphogenetic process involving apical cell constriction.  Given the
existence of other ventral furrow regulators in flies, I then examined the role of Abl in
relation to other regulators.  In addition to examining embryos, I took advantage of a single
cell model of cell constriction (Rogers et al, 2004).  Additionally, as part of this work I
developed and characterized an Abl::GFP fusion to examine Abl localization.  This work is
currently a manuscript in preparation.
Summary
Morphogenesis involves the interaction between various cytoskeletal regulators.
Investigating the interplay between cytoskeletal regulators during a given morphogenetic
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event will aid in our understanding of animal development.  Previous studies of ventral
furrow formation, a morphogenetic event during Drosophila gastrulation, identified a
signaling pathway involving the G-α protein Concertina (Cta) and the Rho activator
RhoGEF2.  While these regulators act to promote myosin accumulation and apical cell
constriction, loss-of-function phenotypes for each of these pathway members is not
equivalent, suggesting the existence of additional ventral furrow regulators.  Here, we report
the identification of Abelson kinase (Abl) as a novel ventral furrow regulator.  We find that
Abl kinase acts apically to suppress apical accumulation of both Enabled (Ena) and actin in
mesodermal cells during ventral furrow formation.  Further, we find that RhoGEF2 mutants,
but not cta mutants, also accumulate apical actin during ventral furrow formation.  Taken
together, our observations identify regulation of apical actin as a critical component that
cooperates with Cta signaling during apical constriction in the Drosophila ventral furrow.
These observations point to a conserved mechanism for Abl kinases in the regulation of actin
during apical cell constriction.
Introduction
During embryonic development, many morphogenetic events shape the future body
plan.  These events rely on shape changes that occur at the level of single cells but must be
coordinated within the context of a tissue.  While developmental biologists have categorized
each morphogenetic process by describing the particular cell shape changes that occur,
execution of these events at a molecular level is not well understood.   Most cell shape
changes will require core cytoskeletal components such as actin and myosin, and thus
cytoskeletal regulatory proteins are likely to dictate the type of cell shape change.
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Identifying how these regulators of morphogenesis work together will aid in understanding
how a group of cells execute a particular shape change.
Drosophila embryogenesis offers an attractive model to study the regulation of
morphogenesis.  A number of morphogenetic events during embryonic development have
been characterized.  These events occur in distinct cell populations and at specific times, and
are likely to share mechanisms with the morphogenetic events that shape vertebrate
development.  Through loss of function studies, a number of mutants have been identified
that affect particular processes.  The formation of the ventral furrow is one such event.
During gastrulation, a subset of mesodermal precursor cells along the ventral midline of the
embryo apically constrict in a highly coordinated fashion.  This constriction creates an
invagination known as the ventral furrow that internalizes these cells as a tube; they then
undergo an epithelial-mesenchymal transition.  The internalization of ventral furrow cells
also brings together the two rows of cells which later will form the central nervous system
(CNS) midline.
Forward genetic screens identified two ventral furrow regulators that give insight into
how the process works: the secreted ligand Folded Gastrulation (Fog, Wieschaus et al 1984;
(Costa et al., 1994; Sweeton et al., 1991)and the G-α protein Concertina (Cta, (Parks and
Wieschaus, 1991; Schupbach and Wieschaus, 1989)Loss-of-function mutations for either
gene disrupt ventral furrow formation by disrupting the coordination of apical cell
constriction.  In these mutants, constriction occurs but in an uncoordinated fashion,
disrupting tube formation (Parks and Wieschaus, 1991; Sweeton et al., 1991) Further studies
established that the mesodermal transcription factors Twist and Snail specify fog expression
in ventral furrow cells (Costa et al., 1994), and that Fog acts upstream of Concertina (Morize
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et al., 1998).  The G-protein coupled receptor that receives the Fog signal remains
unidentified.
Next, a link between Fog/Cta signaling and the cytoskeleton was found, with the
molecular identification of another regulator of the ventral furrow, the Rho1 activator
RhoGEF2 (Barrett et al., 1997; Hacker and Perrimon, 1998).  Epistasis experiments in
embryos and cultured Drosophila S2 cells showed that RhoGEF2, which has a G-protein-
interacting RGS domain, acts downstream of Cta (Barrett et al., 1997; Rogers et al., 2004).
Downstream of RhoGEF2, the ventral furrow pathway signals through Rho1 to direct non-
muscle myosin II (hereafter, myosin) accumulation.  Cta, Rho1, and RhoGEF2 are sufficient
for myosin accumulation and cell constriction in S2 cells (Rogers et al., 2004), and fog, cta,
and RhoGEF2 mutants exhibit defects in apical myosin localization in the ventral furrow
(Dawes-Hoang et al., 2005; Nikolaidou and Barrett, 2004).
While a pathway for apical constriction signaling in the ventral furrow has been
identified, loss-of-function analysis suggests that unidentified players in this process exist.
While fog and cta null mutants internalize mesoderm, albeit abnormally, RhoGEF2 null
mutants exhibit a more severe phenotype, where apical constriction fails entirely and
mesoderm remains on the surface of the embryo after gastrulation.  This difference in
phenotypic severity suggests that RhoGEF2 regulates apical constriction by both Cta-
dependent and independent mechanisms.  In addition to identifying other ventral furrow
regulators, the role of actin in ventral furrow formation has not been closely explored.
Here, we report that Abelson kinase (Abl), plays a role during ventral furrow
formation.  Abl family kinases are unique among non-receptor tyrosine kinases in that they
contain C-terminal actin binding domains.  Mammalian Abl family members regulate actin
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dynamics in a variety of cultured cell types (reviewed in (Woodring et al., 2003).  Loss of
both Abl and the Abl-related-gene (Arg) during mouse development disrupts actin
organization during neural tube closure, resulting in developmental defects (Koleske et al.,
1998).  This process mirrors ventral furrow formation, as it involves apical cell constriction
to create an invagination in the embryo, leading to neurectoderm internalization.
Interestingly, Rho signaling has also been implicated in neural tube formation as mutants in
p190RhoGAP, an Arg substrate in cultured neurons (Hernandez et al., 2004), exhibit
malformed neural tubes (Brouns et al., 2000).
In Drosophila, Abl contributes to both axon guidance and epithelial morphogenesis.
In the developing CNS, Abl negatively regulates Enabled (Gertler et al., 1995) and acts
synergistically with a variety of axon guidance regulators (reviewed in (Lanier and Gertler,
2000).  Among these are the Rho family GEF Trio (Forsthoefel et al., 2005; Liebl et al.,
2000).  Previously, we found a role for Abl during dorsal closure, a morphogenetic process
whereby the embryo is enclosed in a single epithelium (Grevengoed et al., 2001).  To better
understand Abl’s mechanism of action, we examined abl mutant embryos during the simple
stages of blastoderm development.  These studies suggested that Abl’s primary mechanism
of action is to negatively regulate Ena at the apical region of epithelial cells.  In Abl’s
absence, Ena accumulates apically and has adverse effects on actin- instead of polymerizing
in basal membrane furrows, actin accumulates in apical microvilli (Grevengoed et al., 2003).
Here, we describe a novel role for Abl in morphogenesis.  We find that during
gastrulation, Abl regulates apical constriction during mesoderm internalization.  Abl’s
regulation of Ena appears key in this event, as Ena is down-regulated in wild-type but hyper-
accumulates in abl mutant mesoderm.  Using new localization tools, we find that Abl
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concentrates at sites of apical constriction.  Further, the localization of known apical
constriction regulators is altered in Abl’s absence, similar to embryos lacking Cta.  However,
unlike Cta, Abl regulates apical actin organization in both embryos and cultured S2 cells.
We also find that RhoGEF2 regulates apical actin during ventral furrow formation.
Importantly, cta; abl double mutants resemble RhoGEF2 mutants.  These results suggest that
1) an ordered apical actin network (regulated by Abl and RhoGEF2) and 2) stabilized
RhoGEF2 (regulated by Cta) cooperate to direct proper myosin-based contraction.  Further,
this work suggests a conserved role for Abl family kinases in the regulation of apical cell
constriction.
Materials and Methods
Abl::GFP
Using standard molecular techniques, abl coding sequence from cDNA clone GH09917
(Drosophila Genome Resource Center, DGRC) was fused 5’ of the egfp start, introducing a
twenty-one nucleotide linker between abl and egfp and removing the abl stop.  For pUAS
Abl::GFP, this was cloned into pUASG.  For the endogenous promoter construct, two
kilobases directly 5’ of the abl start from BAC clone AC010688 (DGRC) were introduced 5’
of the abl::GFP fusion.  The resulting construct was cloned into the vector pUASG.  DNA
was introduced into flies via standard P-element mediated transposition.  abl::GFP flies
carrying the transgene were crossed into an abl1/abl4 mutant background, and rescue was
confirmed in adults by the absence of wild-type, non-GFP tagged Abl on a Western blot.
Fly Stocks
Mutations are described at flybase.bio.indiana.edu.  FRTRhoGEF204291 flies were from U.
Hacker (Lund University). ctaRC10 flies were from E. Wieschaus (Princeton University).  cta
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mutant embryos were generated by crossing cta heterozygotes to flies carrying Df(2L)C’,
which lacks cta.  abl and RhoGEF2 germline clones were generated as described for abl in
Grevengoed et al (2001).  All experiments were done at 25°C.  Live imaging utilized wild-
type or mutant embryos expressing moesin::GFP (Edwards et al., 1997).
S2 Cells
Cell culture was as in (Rogers et al., 2002).  RNAi was as in (Clemens et al., 2000).  Double-
stranded RNA: templates for in vitro transcription were generated by PCR with the primers
encoding the T7 promoter sequence upstream of the following:  abl-
5’ACTGCATCTCCAGTTCCAGC3’ and 5’ACTGCATCTCCAGTTCCAGC3’, control
(from pBluescript SK).  Transient transfections were done using the Effectene kit (Qiagen).
DNAs used were UAS-ctaR277HMyc, UAS-rhoV14 (both from S. Rogers, UNC), and UAS-
abl::GFP.  Gene expression was driven from the metalothionine promoter by addition of
500µM copper sulfate to the culture medium 24 hours prior to fixation.  Cells were spread on
.5mg/ml ConA for 30 minutes prior to fixation.
Immunofluorescence
For myosin and RhoGEF2 staining, embryos were heat-Methanol fixed (Muller and
Wieschaus, 1996).  For phalloidin and Ena staining, embryos were fixed for 5 min. in 37%
formaldehyde.  All other fixations were in 1:1 heptane:3.7% formaldehyde for 20 minutes.
Embryos were methanol-devitellinized (or hand-devitellinized for phalloidin), blocked and
stained in PBS/1% goat serum/0.1%TritonX-100. S2 cells were fixed as in Rogers et al
(2004).  Antibodies: anti-DE-CAD2 (1:100), anti-Neurotactin (1:10), anti-β-PS1integrin
(1:3), anti-Rho1 (1:100), anti-Ena (1:200), anti-Myc (1:300), anti-ArmN2 (1:200; all
Developmental Studies Hybridoma Bank, DSHB), anti-Twist (1:2000; S. Roth, Max Planck
81
Institute), anti-Sim (1:50; S. Crews, UNC), anti-GFP (1:2000; Abcam), anti-RhoGEF2
(1:2000; S. Rogers), for Myosin, anti-Zipper (1:1250; C. Field, Harvard University), anti-
Phospho-Tyrosine (1:1000, Upstate Biotech.), anti-Phospho(Y412)-c-Abl (1:250;
BioSource), anti-Phospho-(Ser19)Myosin (1:200; Cell Signaling).  Alexa-phalloidin
(Molecular Probes) was used at 1:200.  Secondary antibodies were Alexas 488, 568, and 647
(Molecular Probes).  Cross-sectioning of embryos was as in Dawes-Hoang et al (2005).  All
samples were mounted in Aqua-Polymount (Polysciences).  Fixed samples were imaged
using Zeiss LSM 510 or Pascal confocal microscopes and LSM software.  Live imaging used
a Perkin-Elmer Ultraview spinning-disc confocal, an ORCA-ER digital camera
(Hamamatsu), and Metamorph software.  All images were acquired at 40X.  Adobe
Photoshop 7.0 was used to adjust brightness and contrast.  For level comparisons, great care
was taken to equally adjust compared images.
Immunoblotting
Samples were analyzed by 6% SDS-PAGE, transferred to nitrocellulose and immunoblotted
with anti-Abl (1:100; (Grevengoed et al., 2001)and anti-Pnut (1:30; DSHB).
Results
Abl regulates apical constriction in the ventral furrow
Our previous work examining embryos prior to gastrulation established a role for Abl
in regulating the type and location of actin polymerization, by regulating the localization of
Ena, an actin regulator.  We sought to use this mechanistic insight to return to our study of
Abl’s roles in morphogenesis.  Abl’s pre-morphogenesis roles pose a problem for this effort,
since during cellularization, embryos maternally mutant for abl4, a protein null allele
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(Bennett and Hoffmann, 1992), have defects in the formation of cellularization furrows due
to excess apical actin.  However, we also found that the severity of these phenotypes varies
with temperature: at 18°C most embryos have a large percentage of multinucleated cells due
to mis-localization of actin from basal membrane furrows to apical microvilli, while at 25°C
many embryos have few to no multinucleated cells (Grevengoed et al., 2003).
In this report, we took advantage of this to follow abl mutant embryos with weak
blastoderm phenotypes into epithelial morphogenesis.  This analysis revealed that abl mutant
embryos progress through the stages of morphogenesis relatively normally until dorsal
closure or germband retraction, when the majority of maternal and zygotic mutant embryos
exhibit numerous morphological abnormalities (Grevengoed et al., 2001)data not shown).
However, our analysis also revealed a fully penetrant defect earlier in development, specific
to the ventral epidermis.  We went on to characterize this ventral defect further.
Following cellularization of the blastoderm, the embryo gastrulates.  This process
involves two main types of cell shape changes: apical constriction that internalizes cells of
the ventral furrow and posterior midgut (Sweeton et al., 1991)and cell-cell intercalation that
extends the length of the germband in the anterior-posterior axis (Irvine and Wieschaus,
1994).  abl mutant embryos show no defects in germband extension, as comparison with
wild-type embryos shows similar A-P axis length at the end of gastrulation (Fig.1A vs. B).
To confirm that cell-cell intercalation in the germband is unaffected by loss of abl, we filmed
embryos expressing Moesin::GFP, which highlights the F-Actin cytoskeleton (Edwards et al.,
1997).  This analysis confirmed that the rearrangements of cell-cell contact that drive
germband extension (Bertet et al., 2004)occur normally in abl mutants (Fig.1C vs. D).
However, abl mutant embryos display consistent ventral abnormalities (Fig.1A vs. B, arrows,
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Fig.1O vs. P).  As this phenotype is fully penetrant, this stage of development appears to
depend solely on the maternal supply of Abl.  This result prompted us to investigate ventral
morphogenesis in abl mutants in detail, focusing on the earliest morphogenetic event in these
cells- the formation of the ventral furrow.   We were particularly interested in this process
because it closely mimics a process that fails in mice mutant for both abl and arg: neural tube
closure (Koleske et al., 1998).
Ventral furrow formation is triggered by the regional expression of the transcription
factor Twist, which directs cells into a mesodermal fate.  Previous analysis showed that the
first stage in furrow formation involves the apical constriction of individual cells located at
random positions within the Twist-expressing domain.  In wild-type embryos, the central
constricting population of mesodermal precursor cells transition quickly from uncoordinated
to coordinated apical constriction as the ventral furrow forms (Sweeton et al., 1991).
We analyzed wild-type development in detail, using surface and cross-sections, as
well as time-lapse analysis of living embryos to analyze cell behavior.  While the centermost
cells (Fig.1E, arrow) apically constrict to adopt a triangular wedge shape (Fig.1K, arrow), the
more lateral cells (Fig.1G, arrow) of the furrow do not constrict but adopt an asymmetrical
morphology in order to position their apical ends towards the furrow (Fig.1K, arrowhead,
(Leptin and Grunewald, 1990).  Most remarkable are the outer-most furrow cells, which send
their apical ends far over several neighboring cells to project towards the center of the
developing furrow (Fig.1I, arrow).  The difference in morphology between central
constricting cells and the more lateral cells likely reflects the lack of fog expression in these
latter mesodermal cells (Costa et al., 1994).
84
abl mutant embryos exhibit striking differences from wild-type soon after the onset of
ventral furrow formation.  In contrast to the wild-type process, which is highly coordinated,
in abl mutants we observed uncoordinated apical constriction throughout ventral furrow
formation (Fig.1F,J).  While some cells and groups of cells apically constrict, other cells
appear completely un-constricted.  In grazing sections, these non-constricted cells appear as
large, rounded cells (Fig.1F, arrowhead) next to patches of smaller, constricted cells (Fig.1F,
arrow).  In cross sections, the consequence of this failure to constrict on the morphology of
the ventral furrow is evident.  Instead of the central domain of cells constricting to a common
point, constriction instead occurs in regions interspersed by non-constricted cells (Fig.1J,
arrowhead).  As ventral furrow formation continues, this uncoordinated constriction alters the
shape of ventral furrow cells (Fig.1K vs. L), which are pulled into the furrow at varying
angles (Fig.1G vs. H).
One possibility for this phenotype is that Abl is required for mesoderm specification.
To examine whether the non-constricting cells in abl mutants are correctly specified as
mesoderm, we examined expression of the mesodermal transcription factor Twist.  All cells
in abl mutant ventral furrows are Twist positive (Fig.1 M vs. N), suggesting that fate
specification is not altered.
We next examined the process of ventral furrow formation in living embryos, to
examine how individual cell behaviors drove the overall process.  This also allowed us to
address a possible caveat not ruled out our fixed embryo analysis: non-constricting cells in
abl mutants could represent multinucleated cells from earlier blastoderm stage defects.  To
see if this was the case, we examined ventral furrow formation live in wild-type and abl
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mutants. To ensure that multinucleate cells do not cause abl mutant defects, we only filmed
abl mutant embryos that had no multinucleated cells at the outset (Fig.1R, t=0 min.).
Imaging of wild-type embryos revealed that mesodermal cells constrict uniformly and
internalize synchronously.  The difference between central and lateral cells of the furrow is
evident in these movies- central cells uniformly constrict as they are internalized (Fig.1Q,
t=10 min., Movie 1), whereas lateral cells do not constrict but elongate their apical ends,
which orient towards the furrow as they are internalized (Fig.1Q, t=20min., Movie 1).
In contrast to wild-type, cell constriction in abl mutant embryos is uncoordinated, and
some cells completely fail to constrict.  These defects arise as soon as cell shape change
initiates in the central, constricting population of ventral furrow cells (Fig.1Q vs. R, t=10
min., insets, Movie 2).  When groups of neighboring cells constrict, they often appear to pull
non-constricting cells neighbors toward them and often carry them inside.  Other non-
constricting cells persist on the surface of the embryo after the majority of cells internalize
(Fig.1R, t=20, 25 min., arrow, Movie 2).  These persistent cells may contribute to
irregularities in the shape of ventral midline cells in many abl mutant embryos (Fig.1O vs.
P).  However, the majority of abl mutant embryos eventually internalize all mesoderm,
allowing the two rows of midline cells to meet, as verified by localization of the midline
marker single-minded (Fig.1O’ vs. P’).  Despite the defects in the coordination of cell
constriction, those cells which do invaginate in abl mutants can drive formation of a furrow
(with some abnormalities) in a time period roughly equivalent to wild-type (Fig.1Q vs. R,
compare Movies 1 and 2).
Our use of moesin::GFP also enabled us to visualize actin dynamics in abl mutants
during ventral furrow formation. At the onset of apical constriction in abl mutants, ectopic
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apical patches of actin are present (Fig.1R, t=0 min., arrow).  These are likely remnants of
the excess microvillar actin that accumulates apically in abl mutants during cellularization
(Grevengoed et al., 2003).  This apical actin is less prominent during the course of furrow
invagination.  We analyze the contribution of actin localization to the abl ventral furrow
phenotype in detail below.  Taken together, these results suggest that during gastrulation, Abl
regulates apical constriction in the ventral furrow but appears dispensable for the cell
intercalation events of germband extension.
Abl localizes and is activated apically in embryonic epithelia
To better understand Abl’s role during apical constriction, we investigated the
localization of Abl during normal ventral furrow formation.  Our previous mechanistic
analysis of Abl function during embryogenesis (Grevengoed et al., 2003)suggested that Abl
acts in the apical region of the forming cells.  This observation is consistent with previous
studies of Abl localization (Bennett and Hoffmann, 1992).    We took two approaches to
examine Abl localization and test the hypothesis that Abl is active apically.  First, we used a
GFP-tagging strategy previously used to study mammalian Arg::YFP in Swiss 3T3 cells
(Wang et al., 2001).  This strategy involved adding a C-terminal fluorescent protein tag
joined by a short leader peptide (Fig.2A).  We cloned this Abl::GFP fusion downstream of
two kilobases of Abl 5’ flanking sequence, previously shown to be sufficient for expression
of a rescuing transgene (Henkemeyer et al., 1987).  When introduced into flies, this Abl::GFP
construct completely rescues abl mutants to viability and fertility, suggesting that the protein
encoded by this transgene accurately replicates endogenous Abl expression and localization.
As a second approach, we used a Phospho-specific antibody raised against a Tyrosine residue
in the activation loop of the kinase that is specifically phosphorylated during Abl activation.
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This phosphorylation site is conserved in fly Abl, and we have shown that this antibody
recognizes Drosophila Abl in its active form (Jesse et al, in preparation).  Both reagents
revealed a pool of Abl that concentrates at the apical cortex of epithelial cells.
We began our analysis of Abl localization during cellularization, where we had
previously hypothesized Abl to act apically.  Indeed, both Abl::GFP and phospho-Abl
localize apically (Fig.2 C,D,F,G,H) and cortically (Fig.2 B,E) during cellularization.  At mid-
cellularization, a small pool of Abl also localizes to the basal furrow canal (Fig.2G, arrow),
where the majority of actin and myosin localize at this stage.  Abl also overlaps adherens
junctions (AJs), as shown by colocalization with DE-Cadherin (Fig.2H-H’’).  However, Abl
also localizes more apically (Fig.2H), where other actin-associated apical proteins reside
(Harris and Peifer, 2005).
Next, we examined Abl localization during gastrulation.  As ventral furrow cells
change shape, both total (Fig.2I, K, L) and active (Fig.2J, M, N) Abl concentrate at sites of
apical constriction. Abl also localizes to sites of apical constriction in the posterior midgut
during its invagination (Fig.2O).  Interestingly, towards the end of ventral furrow formation,
a pool of Abl concentrates basally at sites of contact between internalized mesoderm and the
neighboring epithelia (Fig.2P, arrow).  This may represent integrin-based contacts, as this
basal population of Abl colocalizes with Beta-PS integrin (Fig.2S).  We previously observed
this same pool of Beta-PS integrin to colocalize with Rho1 (Fox et al., 2005). Following
gastrulation, Abl::GFP and phospho-Abl strongly localize to the apical cortex of all epithelial
cells (Fig.2Q, R).  Thus, these new Abl localization tools revealed that Abl localizes and is
active apically, and its localization and activity are elevated at sites of apical constriction.
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Apical myosin fails to uniformly contract in abl mutants
Recent work in both embryos and S2 cells has elucidated the mechanism by which
the RhoGEF2 pathway promotes cell constriction.  These studies established that RhoGEF2
promotes myosin organization into an apical contractile ring in constricting cells (Nikolaidou
and Barrett, 2004; Rogers et al., 2004).  To understand how loss of Abl may affect this apical
constriction machinery, we compared the localization of both myosin and RhoGEF2 in wild-
type and abl mutant ventral furrows.
Myosin and RhoGEF2 largely colocalize during wild-type ventral furrow formation.
During cellularization, our analysis confirmed what was previously described: myosin and
RhoGEF2 localize basally to furrow canals during the progression of cellularization
(Fig.3A,I, (Dawes-Hoang et al., 2005; Padash Barmchi et al., 2005; Grosshans et al., 2005).
Following cellularization, most cells retain myosin in the basal yolk canal that is the remnant
of the cellularization contractile apparatus.   However, cells destined to form mesoderm
strikingly relocalize myosin to the apical end of the cell at or just prior to the onset of
constriction (Fig.3C, E, G and (Nikolaidou and Barrett, 2004).  We also examined the levels
of active myosin, using an antibody against the Ser-19 phosphorylation site.  Cells
undergoing constriction exhibit elevated levels of active myosin in the apical region (Fig.
3Q).  Unlike myosin, RhoGEF2 disappears from basal furrow canals at gastrulation onset
(Fig.3I; this transition occurs slightly earlier in the mesoderm), exhibiting a diffuse apical
localization in all cells (Fig.3J).  Next, like myosin, RhoGEF2 accumulates at the apical AJs
of mesodermal precursors (Fig.3K, (Grosshans et al., 2005).  Apical RhoGEF2 can be seen in
cells that have not yet begun to constrict, suggesting that like myosin (Nikolaidou and
Barrett, 2004), apical localization of RhoGEF2 precedes constriction.  In fact, it was much
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easier to identify embryos with apical RhoGEF2 prior to cell constriction, suggesting that
RhoGEF2 may precede myosin to the AJ.  RhoGEF2 localization during mesoderm
internalization parallels both myosin and Abl localization- it accumulates strongly at sites of
apical constriction in the ventral furrow (Fig.3M, O).
We next examined myosin and RhoGEF2 localization in abl mutants.  The
localization of these apical constriction regulators appears largely normal in abl mutants,
including the basal localization of myosin in furrow canals (Fig.3B) and the apical
relocalization of both myosin and RhoGEF2 in mesodermal precursors (Fig.3D, L).  In cross
sections, constricting cells of abl mutants exhibit normal localization of myosin and
RhoGEF2 (Fig.3F, N, arrows), and normal levels of active (Ser-19 phosphorylated) myosin
(Fig.3Q, R).
In contrast, however, in non-constricting cells of abl mutants, the constriction
machinery localizes apically but does not assemble into an effective contractile ring.  This is
observed in grazing sections as diffuse apical staining in the region of the ventral furrow
(Fig.3H, P, arrowheads) or in cross section as areas of faint or absent staining (Fig.3F, N,
arrowheads), depending on where in a cell a particular section was cut. This abl phenotype
contrasts that of non-constricting cells in armadillo mutants, which lack adherens junctions.
In these mutants, the myosin network contracts without constricting the cell itself (Dawes-
Hoang et al., 2005).  Taken together, our results suggest that the apical constriction
machinery localizes properly but fails to contract in non- constricting cells of abl mutants.
cta mutants resemble abl mutants
During ventral furrow formation in abl mutants, cell constriction is uncoordinated yet
mesodermal cells do internalize.  This phenotype resembles the previously described
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phenotypes of cta and fog mutants (Parks and Wieschaus, 1991; Sweeton et al., 1991).  To
understand how Abl function relates to that of other known ventral furrow regulators, we
examined the cta phenotype in detail.
Our analysis showed striking similarities between abl and cta mutants, and also
revealed new details about ventral furrow defects of cta mutants. Cell morphology in cta
mutant ventral furrows closely resembles abl ventral furrows.  In cta mutants, regions of
constricted cells appear next to un-constricted cells (Fig.4A, C, (Parks and Wieschaus, 1991).
Further, mesodermal cells are internalized at varying angles (Fig.4B) and exhibit aberrant
morphology (Fig.4D).  The severity of this phenotype appears comparable to abl mutants
(compare Fig.1 to Fig.4).
We next examined the localization of the apical constriction machinery in cta
mutants.  Previously, Nikolaidou et al (2004) reported a lower level of apical myosin in
constricting cells in cta mutants than in wild-type.  However, when we imaged wild-type and
mutant embryos stained and imaged together, we saw no decrease in apical myosin levels in
constricting cells relative to wild-type (Fig.4G vs. Fig.4H).  We should note that we did find
sections with little or no apical myosin, but suspect these are sections that passed through few
or no constricting cells.  Similar to abl mutants, myosin failed to assemble into contractile
structures in non-constricting cells of cta mutants (Fig.4E).  As in abl mutants, RhoGEF2
concentrates only at sites where cells successfully underwent apical constriction (Fig.4F, I vs.
J), consistent with the idea that the failure of myosin contraction in cta mutants is RhoGEF2-
dependent.  Thus, both abl and cta mutants exhibit regions of non-constricted cells where
RhoGEF2 and myosin fail to assemble a contractile network.
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Abl promotes Actin accumulation while Cta promotes Myosin accumulation in S2 cells
Our loss of function studies suggested that both Abl and Cta promote myosin-based
contraction during ventral furrow formation.  To better understand how these two proteins
function in this process, we took advantage of a single cell assay for myosin organization
during cell constriction in S2 cells.  Previously, overexpression of RhoGEF2 pathway
components including active forms of Cta and Rho were shown to promote myosin
accumulation in these cells (Rogers et al., 2004).  Overexpression of constitutive active
RhoV14 (Paterson et al., 1990) also promotes actin accumulation (S. Rogers, pers. comm.).
We thus examined both myosin and actin localization in S2 cells in response to Abl, Cta, and
Rho overexpression.  Additionally, we used the accessibility of the S2 cell system in both
overexpression through transfection and loss of function through RNAi to test whether Abl
may function in the RhoGEF2 signaling pathway.  To overexpress Abl, we cloned the
Abl::GFP construct lacking the promoter region into a UAS expression vector (Fig.5A).  We
then drove expression of this construct using metalothionine-Gal4.
Expression of Abl in S2 cells results in increased overall tyrosine kinase activity, as
assessed by Phospho-Tyrosine levels (Fig.5B-B’).  In roughly one half of these cells, the
morphology changes from a smooth, continuous peripheral edge to one containing numerous
projections (Fig.5C).  Further, these UAS-Abl cells contain increased levels of peripheral
actin (Fig.5C’, seen in 23/50 cells).  In contrast, these cells exhibit normal levels of
P(Ser19)myosin (no change in 45/50 cells, Fig.5C’’).
Overexpression of Cta in S2 cells produces a very different result from Abl-
overexpression.  As in Rogers et al (2004), we saw that myosin levels increase in response to
overexpressed active (R277H, (Morize et al., 1998) Cta::Myc (Fig.5D’’, seen in 30/50 cells).
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In contrast, these cells do not exhibit a consistent increase in actin levels (Fig.5D’, no change
in 43/50 cells).  Thus, Abl and Cta appear to promote actin and myosin accumulation,
respectively, in S2 cells.
Overexpression of RhoV14 results in an increase of both actin (Fig.5E’, seen in 37/50
cells) and Phospho-(Ser19)myosin (Fig.5E’’, seen in 49/50 cells) levels in S2 cells.  Unlike
in UAS-Abl cells, the actin accumulation in RhoV14 cells localizes to a ring above the cell
center where it colocalizes with myosin (Fig.5E’’’).  Myosin localization in RhoV14 cells
differs qualitatively from most CtaR277H cells in that it localizes into a smaller ring-like
structure (Fig.5E’’ vs. Fig.5D’’), as was previously observed in constricting S2 cells (Rogers
et al., 2004).  Thus, Rho overexpression combines elements of both Abl and Cta
overexpression by concentrating increased levels of actin and active myosin into a ring-like
contractile structure.
We next asked whether Abl acts in concert with Rho during S2 cell constriction.
Specifically, we asked whether Abl is required for the Rho gain-of-function phenotype by
performing control and abl RNAi in RhoV14 cells.  Despite efficient knockdown of Abl
protein (Fig.5), the actin and Phospho-(Ser19)Myosin Rho overexpression phenotypes are
unaffected in abl RNAi cells relative to controls (Fig.5F’’’ vs. Fig.5G’’’).  This result
suggests that Abl does not act downstream of Rho signaling in S2 cells.
Abl regulates Enabled and Actin during ventral furrow formation
Our results from overexpression in cultured cells combined with the earlier work on
Abl as an actin regulator in both flies and mammalian cells suggested that Abl might regulate
myosin-based constriction during ventral furrow formation via its effects on actin.  To test
this hypothesis, we examined whether Abl regulates Ena and thus actin localization during
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ventral furrow formation.  Prior to apical constriction, actin localizes predominantly to basal
furrow canals, while Ena has no specific localization pattern (Fig.6A-A’’; (Grevengoed et al.,
2003).  As ventral furrow formation begins, actin relocalizes apically in ventral furrow cells
and disappears from its basal location (Fig.6B, D, arrow), similar to myosin (Fig.3).  At this
time, a distinguishable pool of Ena begins to localize at apical AJs in most cells (Fig.6C,
arrow).  However, Ena remains noticeably absent from cells of the ventral furrow as apical
constriction initiates (Fig.6C, arrowhead).
Loss of Abl disrupts both Ena and actin localization during ventral furrow formation.
Prior to cell constriction, abl mutants exhibit a considerable amount of ectopic apical actin
that colocalizes with ectopic apical Ena (Fig.6E-E’’; (Grevengoed et al., 2003).  This actin
localization mirrors the patches of F-Actin seen prior to constriction in our live analysis
(Fig.1, t=0min., Movie 2).  The ectopic apical actin persists throughout the embryo as ventral
furrow formation begins (Fig.6F).  As gastrulation proceeds in mutant embryos, actin persists
apically but is also present along the lateral membranes of all mesodermal cells, in contrast to
the highly apically polarized distribution of actin in wild-type (Fig.6D vs. Fig.6H).  Further,
apical Ena levels are elevated in abl mutants (Fig.6C vs. Fig.6G).  Importantly, Ena
accumulates in constricting cells of abl mutants- the same cells that exhibit no detectable Ena
localization in wild-type at this stage (arrowheads in Fig.6C vs. Fig.6G).  In summary, Abl
promotes an enhanced down-regulation of Ena in the ventral furrow cells, allowing for
apically polarized actin accumulation in constricting cells.
As the mis-localization of both actin and Ena contributes to other abl phenotypes, we
next examined whether mis-localization of Ena during ventral furrow formation is causative
in the abl ventral furrow phenotype.  We did so by genetically reducing the dose of Ena in an
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abl mutant background and asked if this rescues the abl ventral furrow phenotype.  In
embryos from maternally ena210/+; abl females, the ventral furrow phenotype is largely
suppressed.  In most of these embryos, apical constriction and mesoderm internalization
appeared normal (Fig.6R).  Taken together, these results suggest that while Abl negatively
regulates apical Ena and thus actin localization in all cells, an enhanced Abl-dependent
downregulation of Ena allows for ordered apical actin during ventral furrow formation.
RhoGEF2, but not Cta, regulates Actin localization in the ventral furrow
Our results suggest that in addition to regulation of myosin, regulation of actin is
required for ordered apical constriction in the ventral furrow.  We next asked whether other
ventral furrow regulators also direct actin localization during this process, by examining actin
and Ena localization in cta and RhoGEF2 mutant embryos.  As the abl actin phenotype arises
prior to gastrulation, we examined both cellularization and gastrulation stages.
cta mutants show no defects in actin localization during either cellularization (Fig.6I)
or gastrulation (Fig.6J,L). These results parallel our S2 cell results, where Cta overexpression
has no effect on actin levels (Fig.5).  Further, downregulation of Ena occurs normally in cta
mutant furrows (Fig.6I, K). Thus, while abl and cta mutants exhibit similar ventral furrow
phenotypes, these proteins appear to regulate this process via distinct mechanisms.
In contrast to cta mutants, RhoGEF2 mutants display an actin phenotype very similar
to abl mutants.  During RhoGEF2 mutant cellularization, ectopic apical actin accumulates, as
in abl mutants (Fig.6E vs. Fig.6M; previously reported by Padash-Barmchi et al, 2005).
However, Ena does not accumulate apically at these stages as is seen in abl mutants (Fig.6E’
vs. Fig.6M’).  Ectopic apical actin remains in all cells during ventral furrow formation,
similar to abl mutants (Fig.6F vs. Fig.6N).  However, unlike in abl mutants, Ena is properly
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down-regulated in RhoGEF2 mutant mesoderm (Fig.6G vs. Fig.6O), which remains on the
surface in these embryos. In later RhoGEF2 mutants, actin and Ena localize to a distinct
apical domain (Fig.6Q-Q’’), a defect not seen in abl mutants. Thus, both Abl and RhoGEF2
regulate apical actin organization prior to and during ventral furrow formation.  While Abl
acts via Ena, RhoGEF2 appears to act via a distinct mechanism.
Discussion
Epithelial morphogenesis involves the cooperation of numerous cytoskeletal
regulators.  Here, we identify Abl kinase as an additional input into apical constriction in the
Drosophila ventral furrow.  Our results suggest that in addition to the known signaling
pathway that promotes apical myosin activation, regulation of apical actin by Abl and
RhoGEF2 is also a critical part of this process.  These results highlight the likely
conservation of Abl and Rho signaling in apical constriction.
Actin regulation is a key component of mesoderm internalization
Previous work established myosin as a key output of the RhoGEF2 signaling pathway
during mesoderm internalization (Dawes-Hoang et al, 2005; Nikolaidou et al, 2004; Rogers
et al, 2004).  However, ambiguities remained regarding the circuitry of this pathway, as
RhoGEF2 mutants are more severe than cta or fog mutants.  Here, we suggest that
RhoGEF2’s earlier role in actin organization, during cellularization, accounts for the
difference in phenotype.
Figure 7 presents a model for the roles of each ventral furrow regulator examined in
our study.  This model accounts for the role of each regulator prior to and during apical cell
constriction.  Prior to gastrulation, apical Abl and basal RhoGEF2 act to maintain actin in
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basal furrow canals (Fig. 7A).  In both abl (Fig. 6E; Grevengoed et al, 2003) and RhoGEF2
mutants (Fig. 6M; Padash-Barmchi et al, 2005), ectopic actin accumulates apically (Fig. 7B,
D).  As Fog signaling is not active at this stage, loss of Cta has no effect (Fig. 6I, Fig. 7C).
During gastrulation, two components cooperate to ensure proper mesodermal
constriction: 1) stabilized apical RhoGEF2, achieved through Fog/Cta signaling, and 2)
organized apical actin, mediated by Abl and RhoGEF2 (Fig. 7E).  In an abl mutant (Fig. 7F),
Fog/Cta signaling is present, allowing for RhoGEF2 stabilization and myosin contraction.
However, due to ectopic actin (Fig. 6F), via Ena’s inappropriate accumulation (Fig. 6G), this
signal is not sufficient to allow for myosin contraction in all cells (Fig. 3F).  In a cta mutant
(Fig. 7G), lack of a stabilizing signal for RhoGEF2 prevents stabilized apical myosin.  Thus,
the apical constriction machinery is less stable, resulting in some un-constricted cells (Fig.
4H).  In a RhoGEF2 mutant, both components are absent: the lack of RhoGEF2 prevents
apical myosin stabilization (Dawes-Hoang et al, 2005; Nikolaidou et al, 2004), but in
addition, ectopic apical actin (Fig. 6N) completely eliminates cell constriction in RhoGEF2
mutants (Fig.7H).
Our model points to organized apical actin as an important target of apical
constriction regulators.  While we find that both Abl and RhoGEF2 regulate apical actin, our
data argues that each regulator functions via a distinct mechanism.  First, this phenotype
arises during cellularization, where Abl and RhoGEF2 have distinct, non-overlapping
localization patterns (Fig. 2H vs. Fig. 3I).  Second, while Abl clearly acts through Ena, loss
of RhoGEF2 disrupts actin without altering Ena localization (Fig. 6M’).  Finally, Abl does
not behave as a Rho effector in S2 cells (Fig. 5H).
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Unanswered questions remain regarding regulation of the cytoskeleton during ventral
furrow formation.  Our data points to Ena as in important factor in cytoskeletal regulation in
the mesoderm.  While Ena accumulates outside of the mesoderm during gastrulation, it
remains down-regulated in the ventral furrow.  This persistent down-regulation could be due
to increased Abl activity or could result from the transcriptional re-programming that directs
the epithelial-mesenchymal transition in these cells.  Another unexplored aspect of this
process is the disappearance of both actin and myosin from the base of the constricting cells.
This process occurs normally in all mutants examined here, including RhoGEF2 mutants.
The future identification of basal ventral furrow cues will address whether the loss of basal
actin and myosin is required for constriction and internalization, an important issue regarding
this type of cell shape change.
Abl is required for a specific type of cell shape change
Our examination of the role of Abl during gastrulation lends evidence to the idea that
different cytoskeletal regulators direct distinct morphogenetic processes.  Abl is required for
coordinated apical constriction in the ventral (Fig. 1F), but is dispensable for cell-cell
intercalation in the germband (Fig. 1D).  This phenotype mirrors that of fog mutants, which
have defects in ventral furrow formation (Sweeton et al, 1991) but not in germband extension
(Bertet et al, 2004).  Thus, while both processes require a dynamic reorganization of myosin
(Nikolaidou et al, 2004; Zallen and Wieschaus, 2004), distinct regulators act in each process.
However, the picture becomes more complex when considering other known roles for
ventral furrow regulators outside of the mesoderm.  While Fog, Cta, and RhoGEF2 are
required for apical constriction in the posterior midgut and salivary glands (Nikolaidou et al,
2004; Barrett et al, 1997; Sweeton et al, 1991), Abl appears dispensable for these events (data
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not shown).  This may account for the fact that loss of Fog or Cta more closely resembles
loss of RhoGEF2 in the posterior midgut.  Thus, certain types of apical constriction may
require different levels of regulation.  In the future, it will be interesting to explore the role of
Fog, Cta, and RhoGEF2 during dorsal closure, an Abl-dependent morphogenetic event
(Grevengoed et al, 2001).
A conserved role for Abl and Rho signaling during apical constriction
This study also suggests a mechanistic connection between the fly process of ventral
furrow formation and the vertebrate process or neural tube closure.  Both processes involve
actin-based apical constriction to internalize sheet of cells into a tube-like structure.
Importantly, knockout of the two Abl family kinases in mice results in disorganized actin and
defects in neural tube closure (Kokeske et al, 1998).  Further, mammalian Ena (Mena) also
plays a role in neural tube closure, in conjunction with Profilin (Lanier et al, 1999).  Thus,
Abl/Ena signaling may represent a conserved mechanism of actin regulation during apical
constriction.
Rho signaling also plays a role in neural tube closure.  Mice lacking the Rho regulator
p190 RhoGAP exhibit neural tube defects associated with ectopic F-Actin and a lack of
apical constriction (Brouns et al, 2000).  Interestingly, p190 RhoGAP is a substrate of Arg in
the mouse brain (Hernandez et al, 2004), suggesting a possible direct link between Abl and
Rho signaling in apical constriction.  The role of Drosophila p190 RhoGAP in the ventral
furrow has yet to be examined directly, however the putative RhoGAP68F was recently
implicated in ventral furrow formation (Sanny et al, 2006).  It is likely that work in both fly
and vertebrate systems will aid in understanding conserved mechanisms of apical cell
constriction.
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Drosophila Abl localization: new tools and insights
This study also makes use of new localization tools to understand the role of
Drosophila Abl.  Our initial studies using these tools confirmed what we had hypothesized
previously- that Abl concentrates its activity apically in epithelial cells (Grevengoed et al,
2003).  Future use of these tools will enhance our understanding of Abl function during
morphogenesis.  Use of Abl::GFP will allow for future time-lapse studies of Abl dynamics.
This will be interesting to observe in the context of processes that involve dynamic
cytoskeletal rearrangements.  Additionally, Phospho-Abl localization may pinpoint subsets of
total Abl that are active.  Such observations may identify other developmental processes and
sub-cellular locations where Abl plays a role.
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Fig.4.1.  Abl is required for apical constriction in the ventral furrow.  (A,B) Low
magnification, germband extended embryos, anterior to left, dorsal up, DE-Cad.  (A) Wild-
type, bracket- germband, arrow- ventral midline.  (B) abl mutant.  Arrow shows irregular
midline (compare with A).  (C-D’) High magnification of live embryos, germband (region
near bracket in A), anterior to left, dorsal up, Moesin::GFP .  (C-C’) Wild-type, prior to (C)
and after (C’) cell intercalation.  Note the rearrangement of cell contacts in the quartet of
cells marked with white dots.  (D-D’) abl mutant, prior to (D) and after (D’) cell
intercalation.  Similar junctional rearrangements occur as in wild-type (compare C vs. D, C’
vs. D’).  (E,F,G,H) Grazing sections, ventral, DE-Cad.  (E,F) Apical, early gastrulation.  (E)
Wild-type, arrow shows apically constricting mesodermal cells, all uniformly changing
shape.  (F) abl  mutant, arrow- constricting cells, arrowhead- un-constricted cells in the
region of the mesoderm, identifying a ventral furrow defect (compare E vs. F).  (G, H) Sub-
apical, mid-gastrulation. (G) Wild-type, lateral mesodermal cells (arrow) orient parallel to the
furrow.  (H) abl mutant, lateral mesodermal cells are drawn towards the furrow at varying
angles.  (I, J, K, L) Cross-sections, ventral, Neurotactin (Nrt).  (I,J) Early gastrulation.  (I)
Wild-type.  Central mesodermal cells constrict and point towards the furrow.  Arrow-
outermost constricting cells exhibit dramatic shape changes.  (J) abl mutant.  Arrowhead-
non-constricted cell.  (K,L) Late gastrulation.  (K) Wild-type, arrow- wedge shaped
constricted cells in center of furrow, arrowhead- unconstricted lateral furrow cells, aligned
perpendicular to furrow.  (L) abl mutant.  Asymmetric cell shapes are seen throughout the
furrow.  (M,N) Twist (Green) expression is similar between wild-type (M) and abl mutant
(N) mesoderm (Red, DE-Cad).  (O-P’) Midline morphogenesis (seen with DE-Cad, O,P) and
joining (seen with Single-minded, Sim)  in wild-type (O-O’) and abl mutants (P-P’).  abl
mutants occasionally exhibit irregular cell shapes in the midline (O vs. P), yet the two rows
midline cells properly join (O’ vs. P’).  (Q, R) Stills from live imaging of wild-type (Q) and
abl mutants (R) expressing Moesin::GFP.  Comparison of insets at t=10 minutes (Q vs. R)
highlights the asymmetry in cell shape change in abl mutants.  abl mutants also exhibit
ectopic F-actin patches at the onset of furrow formation (R, t=0 min.), and persistent
mesoderm (R, t=20, 25 min., arrows) in the furrow.
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Fig. 4.2.  Abl localization and activity concentrates apically in embryonic epithelia.  (A)
Schematic of abl::GFP construct.  2kb of 5’UTR acts as an endogenous promoter, and a
short 7 amino acid (a.a.) linker bridges abl  and egfp  coding sequences.  (B-D) Syncytial
blastoderm.  (B) Grazing section, Abl::GFP at the cell cortex.  (C,D) Cross-sections.
Abl::GFP (C) and Phospho-Abl (P-Abl, D) localize apically.  (E-H’) Cellularization.  (E)
Grazing section, Abl::GFP at the cell cortex.  (F-H’) Cross-sections.  (F) Low magnification,
Abl::GFP (green) localizes apically throughout the embryo (Red, Nrt marks all membrane).
(G-H’’) High magnification (G) At mid-cellularization, Abl::GFP can be seen apically but
also faintly in basal furrow canals (arrow).  (H-H’’) Abl::GFP (H, H’’, green) localize
apically and partially overlap with adherens junctions (H’, red in H’’, DE-Cad).  (I-N’)
Ventral furrow.  (I-J) Grazing sections.  Abl::GFP (I, green in I’’) colocalizes with
constricting adherens junctions (DE-Cad, I’, red in I’’).  (J) P-Abl accumulates strongly in
the furrow.  (K-N’) Cross-sections.  Red- Nrt.  (K-L’) Abl::GFP (green in K, L) accumulates
at sites of apical constriction early (K-K’) and late (L-L’) in ventral furrow formation.  (M-
N’) P-Abl (green in M, N) accumulates at sites of apical constriction early (M, M’) and late
(N, N’) in ventral furrow formation. (O) Abl::GFP localizes to apically constricting posterior
midgut cells.  (P) Late in ventral furrow formation, Abl::GFP also resides at a basal structure
(arrow).  (Q-R) Germband extended embryos, apical grazing sections.  Abl::GFP (Q) and P-
Abl (R) localize prominently to the cell cortex.  (S-S’’) Abl::GFP (S, green in S’) overlaps
with Beta-integrin (S’, red in S’’) basally in epithelial cells at gastrulation.  All Abl::GFP
visualization is with anti-GFP.
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Fig. 4.3.  Myosin and RhoGEF2 fail to uniformly assemble a contractile network in abl
mutants.  (A-F’’) Cross-sections.  (A-D) Low magnification.  (A-B) Late cellularization.
Myosin localizes basally in both wild-type (A) and abl mutants (B).  (C-D) Early ventral
furrow formation.  Myosin begins to accumulate apically in both wild-type (C) and abl
mutants (D).  (E-F’’) Close-ups, ventral furrow.  (E-E’’) Wild-type.  Myosin (E, green in E’’)
accumulates apically in cells that constrict (seen with Nrt- E’, red in E’’).  (F-F’’) abl mutant.
Myosin (F, green in F’’) accumulates strongly in constricting cells arrow in (F), but only
faintly in non-constricting cells (arrowhead in F).  Nrt- F’, red in F’’.  (G-H’’) Grazing
sections.  (G-G’’) Wild-type.  Myosin (G, green in G’’) evenly coats the apical surface (seen
with Armadillo- G’, red in G’’) of all constricting mesoderm.  (H-H’’) abl mutant.  Myosin
(H, green in H’’) concentrates most at sites of apical constriction (seen with arrow and with
Armadillo- H’, red in G’’) but is only faintly present elsewhere (arrowhead).  (I-N’’) Cross-
sections.  (I-L) Low magnification.  RhoGEF2 (GEF)- green, Nrt- red.  (I-K) Wild-type.
GEF localizes basally at the end of cellularization but leaves the basal surface of mesoderm
(I), then localizes diffusely and apically everywhere (J), before accumulating strongly at the
apical surface of soon to constrict mesoderm (K).  (L) GEF also accumulates apically on the
ventral surface of abl mutants prior to furrow formation.  (M-N’’) High magnification.  (M-
M’’) Wild-type.  GEF (M, green in M’’) localizes strongly to all apically constricting cells
(seen with Nrt- M’, red in M’’).  (N-N’’)  abl mutant.  GEF (N, green in N’’) localizes
strongly only in constricting cells (arrow in N), but is more diffuse in non-constricting cells
(arrowhead in N).  Nrt- N’, red in N’’.  (O-P)  Grazing sections, ventral.  (O) Wild-type.
Apical GEF localization is uniform throughout the furrow.  (P) abl mutant.  Apical GEF is
strong in places (arrow), and weaker in others (arrowhead).  (Q,R)  Cross sections, ventral,
Phospho-Myosin (P-Myo).  Constant level imaging reveals similar levels of active myosin at
sites of apical constriction in wild-type (Q) vs. abl mutants (R).
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Fig. 4.4.  cta  mutants resemble abl mutants.  (A, B) Grazing sections, DE-Cad.  (A) Early
gastrulation, apical.  cta mutants exhibit large, unconstricted cells (compare to abl, Fig. 1F).
(B) Late gastrtulation, sub-apical.  cta mutants internalize mesoderm at varying angles
(compare to abl, Fig. 1H).  (C, D) Cross-sections, Nrt.  (C) Early gastrulation.  cta mutants
exhibit un-constricted cells in between constricting cells (compare with abl, Fig. 1J).  (D)
Late gastrulation.  cta mutants exhibit asymmetry in mesodermal cell shape (compare with
abl,  Fig. 1L).  (E, F) Grazing sections.  (E) Apical Myosin and (F) GEF accumulation in the
ventral furrow is disrupted (compare to abl- E vs. Fig. 3H, F vs. Fig. 3P).  (G-J’) Cross-
sections.  (G-H’) Myosin (G’, H’, green in G, H) levels are comparable at sites of apical
constriction (cell shape seen with Nrt- red in G, H) between wild-type (G-G’) vs. cta mutants
(H-H’), but in cta mutants Myosin is uneven, similar to abl (see Fig. 3F).  (I-J’) GEF (I’, J’,
green in I, J) levels are comparable at sites of apical constriction (see Nrt- red in I, J) between
wild-type (I-I’) vs. cta mutants (J-J’), but in cta mutants GEF is uneven, similar to abl (see
Fig. 3N).
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Fig. 4.5.  In S2 cells, Abl promotes actin accumulation while Cta promotes myosin
accumulation.  (A) Scheme for UAS-Abl::GFP.  The same fusion diagramed in Fig. 2A, but
the endogenous promoter is replaced with Gal4 UAS sites.  (B-B’) UAS-Abl cells (GFP
positive, B) display increased Abl activity, as assayed by Phospho-tyrosine (P-Y, B’).  (C-
E’’’) Actin (C’, D’, E’) and P-Myo (C’’, D’’, E’’) in UAS-Abl (C-C’’’), UAS-Cta (D-D’’’),
and UAS-Rho (E-E’’’) transfected cells.  (C’’’, D’’’, E’’’) Merged images showing actin in
red and P-Myo in green.  Abl-transfected cells (GFP, C) display increased levels of actin (C’,
C’’’), but not P-Myo (C’’, C’’’).  Cta-transfected cells (Myc, D) display increased levels of
P-Myo (D’’, D’’’) but not actin (D’, D’’’).  Rho-transfected cells (Rho, E) exhibit both
increased actin (E’, E’’’) and P-Myo (E’’, E’’’).  However, both the increased actin and P-
Myo in Rho-transfected cells tightly organize into a central ring-like structure (compare E’
vs. C’, E’’ vs. D’’).  (F-H’’’) abl RNAi does not disrupt the Rho gain-of-function phenotype.
(F-F’’’) Control RNAi, showing low levels of Rho (F), peripheral actin (F’, red in F’’’), and
diffuse P-Myo (F’’, green in F’’’).  (G-G’’’) Control RNAi plus active Rho, showing
increased Rho (G vs. F),  and concentrated actin (G’, red in G’’’) and P-Myo (G’’, green in
G’’’).  (H-H’’’) abl RNAi plus active Rho.  Rho (H), Actin (H’, red in H’’’) , and P-Myo
(H’’, green in H’’’) are identical to G-G’’’.
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Fig. 4.6.  Actin accumulates ectopically in abl and RhoGEF2 mutants, but not in cta mutants.
Wild-type (A-D), abl mutants (E-H), cta mutants (I-L), and RhoGEF2 mutants.  (A-A’’, E-
E’’, I-I’’, M-M’’) Late cellularization.  Actin (A, E, I, M, red in A’’, E’’, I’’, M’’) localize
basally in all genotypes, but accumulates ectopically in abl (E) and RhoGEF2 (M) mutants,
not in wild-type (A) or cta mutants (I).  Ena (A’, E’, I’, M’, green in A’’, E’’, I’’, M’’)
exhibits diffuse localization in wild-type (E’), cta (I’), and RhoGEF2 mutants (M’), but
accumulates apically in abl mutants (E’).  (B, F, J, N) Actin, ventral furrow stage, low
magnification.  Ectopic apical actin is seen in abl (F) and RhoGEF2 (N) mutants, but not in
wild-type (B) or cta (J) mutants.  (C, G, K, O) Ena, ventral furrow, high magnification.  (C)
Ena localizes apically in non-mesodermal cells (arrow), but remains diffuse in mesodermal
cells (arrowhead).  (G) abl mutants accumulate Ena in the mesoderm.  (K, O) Neither cta
mutants (K) nor RhoGEF2 mutants (O) accumulate ectopic mesodermal Ena.  (D, H, L, P)
Actin, ventral furrow, high magnification.  (D) Actin is highly polarized in wild-type, and
disappears from its previous basal location (arrow, compare with A).  (H, P) Actin
accumulates apically in abl mutant (H) and RhoGEF2 mutant (P) ventral furrows.  (L) cta
mutants do not display an excess apical actin phenotype in the ventral furrow.  (Q-Q’)
RhoGEF2 mutants, late gastrulation, low magnification.  Excess apical actin (Q, red in Q’’)
colocalizes with Ena (Q’, green in Q’’) in ectopic structures.  (R) Heterozygosity of ena
suppresses the abl ventral furrow phenotype (DE-Cad).
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Fig. 4.7. A meachanistic model of ventral furrow formation.  Cellularization (A-D) and
gastrulation (E-H) in the mesoderm in wild-type (A,E), abl mutants (B,F), cta mutants (C,
G), and RhoGEF2 mutants (D, H).  A. During cellularization, actin (red) and myosin
(yellow) concentrate in a ring-like pattern in the basal furrow canal, while a small amount of
actin resides in apical microvilli.  B. Excess apical actin forms in abl mutants during
cellularization.  C. Actin and myosin are normal in cta mutants at cellularization.  D.
RhoGEF2 mutants exhibit abl-like actin defects at cellularization.  E.  In mesodermal cells,
actin and myosin translocate apically, and are stabilized by Cta/RhoGEF2 interactions (star).
F.  In an abl mutant, Cta/GEF interactions are transiently blocked by apical actin, resulting in
some non-constricted cells.  G.  In cta mutants, lack of Cta/GEF interactions results in only
transient apical myosin contraction, resulting in some non-constricted cells.  H.  In RhoGEF2
mutants, the combination of no Cta/GEF interactions and the build-up of apical actin
synergize to completely block apical constriction.
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CHAPTER 5
CHARACTERIZATION OF ABL LOCALIZATION AND ACTIVATION
Preface
The following describes unpublished work in which I surveyed Abl localization and
activation in embryos after gastrulation (a pre-gastrulation characterization is provided in
chapter 4).  To do so, I utilized two tools:  Abl::GFP (described in detail in chapter 4) and a
phospho-specific mammalian Abl antibody, for which I provide a detailed characterization
here.  Further, I utilized the phospho-Abl antibody to initiate studies of candidate upstream
Abl activators.  The characterization of the Phospho-Abl antibody is included in a manuscript
that is currently in preparation.  The remainder of this work will be continued by Ed Rogers,
a post-doc in the lab.
Introduction
Abl family kinases have been functionally linked to the actin cytoskeleton in many
contexts.  Studies in cultured mammalian cells have revealed Abl family proteins in different
actin-based structures, such as filopodia and membrane ruffles (reviewed in Woodring et al.,
2003).  These observations suggest that Abl may preferentially localize to sites of actin
reorganization during morphogenesis.  Importantly, however, examining the localization of
all Abl kinase in a cell alone does not necessarily reveal where this kinase is active.  Crystal
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structure studies of Abl bear this out, as Abl appears to require several activation events to
convert to the active form (reviewed in Harrison, 2003).  Thus, it is possible that a majority
of Abl protein is in fact not active.  Therefore, comparing the localization of active and total
Abl may lend additional detail to studies of Abl function.  Further, studying Abl activation
also raises the question of how Abl is activated.  Studies in cultured mammalian cells suggest
that the receptor tyrosine kinases EGFR and PDGFR as well as the non-receptor tyrosine
kinase Src may activate Abl (Tanis et al 2003; Plattner et al 1999).  However, it is not clear
what signals activate Abl in the context of an intact animal.
In the work described below, I initiated a survey of Abl localization and activation in
Drosophila embryos after gastrulation.  I identified a striking localization pattern of Abl
between daughter cells in late cytokinesis.  Abl’s localization at this site differs from other
late cytokinesis markers, suggesting that this late mitotic structure is complex in nature.
Further, I demonstrated that a phospho-specific mammalian Abl antibody recognizes active
fly Abl.  Active Abl localizes to the apical cell cortex and central nervous system in post-
gastrulating embryos.  I then used this active Abl antibody to show that overexpression of
either Drosophila Src42 or pvr can stimulate Abl activation.  Taken together, these results
show that Abl is active in the apical cell cortex, identify a possible role for Abl as a regulator
of cytokinesis, and provide the first evidence of upstream activators of Abl in an intact
animal.
Materials and methods
Immunofluorescence
120
Embryos were fixed in 1:1 PBS+3.7% formaldehyde:heptane for 20 min.  Embryos were
methanol-devitellinized, blocked and stained in PBS/1% goat serum/0.1%Triton-X-100.
Antibodies: anti-phospho (Y412) (1:250), anti-Rho (1:250), anti-phosphotyrosine (1:1000),
anti-phosphohistone H3 (1:500), anti-anillin (1:100), anti-acetylated tubulin (1:2000), and
anti-GFP (1:2000), anti-engrailed (1:50).
Immunobloting
Embryo extracts were separated on 6% SDS-PAGE, transferred to nitrocellulose, and probed
with anti-Abl (1:100), anti-Phospho(Y412) Abl (1:2500), or anti-Pnut (1:30).
Results
Abl localizes to distinct structures late in mitosis
Our previous analysis of Abl localization centered on the blastula and gastrula stages
of development (Chapter 4).  I extended this analysis to later stages of development.  As
during earlier stages, I found Abl::GFP to localize to the apical cell cortex (Fig. 1A, Fig. 4A,
B).  Unlike during gastrulation, Abl::GFP is no longer uniformly around the cortex in all
epithelial cells but is seen in puncta at “tri-cellular junctions” where several cells meet (Fig.
4B, arrow).
One unexpected result was the identification of a striking pattern of Abl localization
in dividing cells.  At the end of cellularization cells arrest in G2 of the cell cycle.  After
gastrulation, embryonic cells enter mitosis in a stereotyped pattern, with groups of cells in
“mitotic domains” entering mitosis synchronously (Foe, 1989).  At the apical cortex, I found
Abl to brightly decorate the boundary between two daughter cells (Fig. 1A, arrow) during
late telophase.  I confirmed this observation by co-staining with phospho-histone H3, which
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marks early mitotic cells.  This marker clearly marks large, pre-anaphase cells (Fig. 1A), but
is absent in recently divided daughter cells within a mitotic domain.  Cells lacking phospho-
histone staining contain a bright boundary of Abl::GFP localization.
My first hypothesis was that Abl may localize to the contractile ring during
cytokinesis.  To test this hypothesis, I co-localized Abl::GFP with the contractile ring marker
Rho1 (Fig. 1B-E).  This analysis revealed that Abl:GFP does not reside in contractile rings
when they are first formed (Fig. 1B, compare Rho1 vs. Abl::GFP).  However, shortly after
contractile ring formation, Abl::GFP does overlap with Rho1 (Fig. 1C,D) and the contractile
ring marker Anillin (Fig. 1E), residing between daughter cells.  The contractile ring is also
bisected by acetylated tubulin (Fig. 1E, F), which marks the spindle midzone, a remnant of
the mitotic spindle and marker between recently divided cells.
Abl::GFP localization within these late mitotic structures differs from Rho1 and
anillin.  While these contractile ring components progressively re-localize into a dot like
structure very late in telophase (Fig. 1D,E for Rho1 and Fig. 1F for Anillin), Abl::GFP
localization occupies a broader domain, possibly flanking this dot-like structure (Fig. 1E,
compare Abl::GFP and Rho1).  Thus, Abl appears to localize between daughter cells in a
temporally and spatially distinct manner to known contractile ring proteins.  This localization
may specifically mark the newly assembled membrane separating the two daughters.
However, the apical membrane protein DE-Cad is not as enriched at the same location as Abl
(Fig. 1B-D, compare Abl::GFP vs. DE-Cad).
Phospho(Y412) Abl: visualizing active Abl in fly embryos
As a second approach to visualizing Abl in late embryos, I utilized a tool that allowed
us to visualize active Abl.   I obtained a commercial antibody against phosphorylated Y412
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in human c-Abl, a residue that contributes to mammalian Abl activation (reviewed in
Woodring et al., 2003).  Alignment of the peptide used to produce this mammalian antibody
with Drosophila Abl shows that 8/10 residues are identical, with a tyrosine in the position
equivalent to Y412 (Fig. 2A).  To demonstrate that this antibody recognizes fly Abl, we
performed Western blot analysis from wild-type and Abl over-expressing embryonic
extracts.  As for anti-Abl, phospho(Y412) Abl recognizes a doublet at ~180 kDa in embryos
overexpressing wild-type Abl and in wild-type embryos (Fig. 2B, star, lanes 1 and 4 from
left).  It also cross-reacts with other proteins above 180 kDa (Fig. 2B, arrows).
Further, this antibody specifically recognizes active Abl.  This is revealed by the
increase in signal in embryos expressing a hybrid mammalian-fly fusion of the overactive
BCR-Abl translocation (Fogerty et al 1999, Fig. 2B lane 2, our generic fly Abl antibody does
not recognize BCR-Abl).  Additionally, while embryos expressing kinase dead Abl contain
elevated levels of total Abl (Fig. 2B lane 3), levels of phospho-Abl are unaltered (Fig. 2B,
compare lanes 1 vs. 3 for phospho-Abl).  Finally, when Abl activation is triggered by
overexpression of wild-type Abl or mis-expression of the p185 or p210 isoforms of BCR-Abl
(which are constitutively active), active Abl is enriched at the cortex of expressing cells (Fig.
2C, D, E, arrows).  Thus, an antibody directed against active mammalian Abl also recognizes
active fly Abl.
Having confirmed that the P(Y412)Abl antibody recognizes active Abl, we next
examined the sub-cellular localization of active Abl in embryos.  When Abl activation is
forced, by overexpression of either wild-type or the p185 or p210 isoforms of BCR-Abl,
active Abl is enriched at the cortex of expressing cells (Fig. 2C,D, E, arrows).  The same
localization trend is true in wild-type embryos throughout embryonic development.  Active
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Abl localizes to the cell cortex during gastrulation (Fig. 3A), germband extension (Fig. 3C),
as well as during (Fig. 3E) and after (Fig. 3G) dorsal closure.
Active Abl is also seen at specific sub-cellular locations in embryos.  Co-localization
with Abl::GFP confirms that the Abl::GFP that accumulates between daughter cells is active
(Fig. 4B, arrowheads). Active Abl is also seen in puncta at tricellular junctions (Fig. 3B, D),
much like total Abl (Fig. 4B, arrowheads).  This localization pattern overlaps that of the Abl
target Ena (Fig. 4C, arrows).  One place where active Abl and Ena localization differ occurs
during dorsal closure.  While Ena accumulates in puncta at the leading edge (Fig. 4D, arrow)
and is enriched in “segmental groove” cells (Fig. 4D, arrowhead), Abl activation is not
similarly enriched at these locations (Fig. 4D).  Finally, active Abl also localizes to the
central nervous system axons (Fig. 3H), as does bulk Abl protein (Bennett and Hoffmann,
1992).  In summary, use of a mammalian phospho-specific Abl antibody recognizes active
Abl protein.  Abl is active at the cell cortex and in CNS axons, and overlaps in many places
with the Abl target Ena.
Src42 and PVR are candidate activators of Drosophila Abl
The ability to visualize active Abl presents the opportunity to identify upstream
signals that activate Abl.  Previous work in cultured cells identified receptor tyrosine kinase
signaling by epidermal growth factor (EGF) and platelet derived growth factor (PDGF) as
upstream signals for Abl activation (Plattner et al., 1999).  To test whether signaling from
these growth factors could activate Abl in Drosophila, I expressed constitutive active forms
of the receptors for both growth factors (EGFR and PVR) in the embryonic epidermis.  To
internally control for expressing vs. non-expressing cells, I used the engrailed-GAL4 driver,
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which drives expression of each construct in alternating stripes of cells (Fig. 5, red channel in
all merged images).
Expression of PVR resulted in an increase in PAbl signal in engrailed-positive cells
(Fig. 5A, A’).  In contrast, expression of active EGFR with the same driver did not change
PAbl signal in engrailed-positive cells (Fig. 5C, C’).  However, I can not rule out EGFR as
an Abl activator, as expression of this tyrosine kinase, unlike PVR expression, did not elevate
phospho-tyrosine levels (Fig. 5B vs. D), calling into question how effectively the receptor
was activated.  I also tested several other EGFR overexpression constructs, including tagged
constructs to verify expression, and none showed elevated phospho-tyrosine.  Thus, while
EGFR expression in our hands does not elevate phospho-tyrosine or phospho-Abl levels,
overexpression of PVR results in increased active Abl.
Next, we examined potential downstream effectors of receptor tyrosine kinases for
potential Abl activation.  The non-receptor tyrosine kinase Src has been shown to activate c-
Abl (Tanis et al., 2003), and PDGF activation of Abl appears to be dependent on Src
(Plattner et al., 2004).  Thus, PDGF may signal through Src to activate Abl.  To test if Src
behaves as an Abl activator in Drosophila, we mis-expressed constitutive active Src42 in
engrailed stripes.  As for PVR overexpression, phospho-tyrosine levels (Fig. 5F) and Abl
activation increase in response to Src overexpression (Fig. 5E, E’).
The MAP kinase pathway is a well-known downstream target of EGF signaling
(reviewed in Schlessinger, 2000).  While we did not see activation of Abl by EGFR
overexpression, we further tested whether EGF-dependent signaling could activate Abl.  To
test this, we overexpressed wild-type Raf kinase.  As for EGFR mis-expression, Raf
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overexpression does not alter levels of Abl activation (Fig. 5G).  Thus, while PVR and Src
are sufficient to activate Abl, EGFR and Raf signaling do not activate Abl.
Discussion
The above experiments represent initial studies of Abl localization and activation in
the post-gastrulating embryo.  Many significant Abl-dependent processes occur during these
stages, such as germband retraction and dorsal closure in the epidermis and axon guidance in
the central nervous system.  By observing when and where Abl is present and active, we
better understand mutant phenotypes and interpret the role of Abl in developmental
processes.
A role for Abl in cytokinesis?
Our previous work showed a clear role for Abl during the cytokinesis-like events of
syncytial mitosis and cellularization.  While these events differ from standard cytokinesis,
they do involve reorganization of the actin cytoskeleton to separate nuclei.  In Abl’s absence,
actin fails to assemble into membrane furrows, resulting in transient multinucleated cells
(Grevengoed et al., 2003).  Whether Abl plays a similar role in late embryogenesis remains to
be determined.  While some late stage abl mutant embryos contain multinucleated cells, it is
unclear whether these are remnants of blastoderm stage defects.  A careful analysis will be
needed to determine whether Abl’s localization to cleavage furrow remnants represents a role
in cytokinesis.
The late localization of Abl between daughter cells suggests that if Abl participates in
cytokinesis, it does so at the very terminal step.  Among the class of late-cytokinesis
regulators are Anillin and Rho (Echard et al., 2004), which overlap Abl localization between
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daughter cells.  These cytokinesis regulators were identified in an RNAi screen in S2 cells,
which did not identify Abl as having this phenotype (Echard et al., 2004).  However, several
knockdowns in this screen produced subtle phenotypes.  It is intriguing to think of how
cytokinesis would proceed if a similar knockdown were performed in conjunction with Abl.
One possible role for Abl might be regulation of membrane deposition of the reformation of
adherens junctions between the daughter cells.
Abl activation: an opportunity for new insights
The ability to analyze active Abl will greatly enhance our understanding of Abl
function. By comparing both total and active Abl, we may better understand where and when
Abl is active.  If specific localization patterns of Abl activity are observed in the future, they
may be predictive of Abl-dependent processes.  The lack of Abl enrichment with Ena in
leading edge puncta and in segmental groove structures is interesting given our lab’s findings
that Abl is required for both leading edge and segmental groove morphogenesis (Grevengoed
et al 2001; Stevens et al, in preparation).  Perhaps a scaffold for Ena is enriched in these
cells, and Abl is still playing its role as a negative regulator at these locations as in other
places.
As preliminary data suggests, the active antibody may serve as a helpful tool for
identifying Abl activators.  The Drosophila community has created a great resource known
as an “EP” library, which is a set of stocks for overexpression of many genes in the genome.
Such a library could be screened through with the Phospho-Abl antibody to identify potential
Abl activators; given the scale of the effort this might be done best by targeting candidate
genes.
A potential cytoskeletal signaling pathway involving Abl
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Our preliminary results implicate Src and Pvr as activators of Abl.  This result must
now be tested more rigorously to functionally connect these kinases to Abl activation.  For
instance, mis-expression of these candidate activators should affect Ena localization.
Further, the mutant phenotypes of candidate activators should resemble, in part, abl
phenotypes.  A recent study of src42 loss of function is encouraging, as these mutant
embryos display germband retraction defects (Takahashi et al., 2005), thus resembling abl
mutants (Grevengoed et al 2001).
An interesting mechanistic picture of PVR function is emerging in another fly model
of morphogenesis.  In migrating border cells of the ovary, both EGFR and PVR have been
shown to act in a non-canonical (not through MAP kinase) signaling pathway to reorganize
the cytoskeleton (reviewed in Gupta and Schupbach, 2001).  Interestingly, both a Src family
member (Somogyi and Rorth, 2004) and Abl (Rorth et al., 1998) have also been implicated in
border cell migration.  Our results suggest that Abl activation is downstream of both PVR
and Src, and is MAPK-independent.  This raises the possibility that Abl may lie downstream
of a receptor tyrosine kinase pathway of cytoskeletal regulation involving at least PVR and
Src.
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Fig. 5.1.  Abl localizes to distinct structures late in mitosis.  All images show mitotic
domains in germband-extended embryos.  A.  Abl::GFP (green) is found at the apical cortex
of all cells (arrow), but is enriched between non-Phospho-Histone H3 (red) positive cells of
mitotic domains.  Blue- DE-Cad marks cell apices.  Note relative to Abl, DE-Cad is not as
enriched at arrow. B. Mitotic domain, early telophase. Contractile rings contain Rho1 (red),
but not Abl::GFP (green) or DE-Cad (blue).  C. Mid-telophase.  Abl::GFP (green) appears
along the boundary between daughter cells, as Rho1 (red) begins to concentrate more at the
center. D.  Later in telophase than C.  Abl::GFP (green) continues to be enriched at the
boundary between daugther cells, while Rho1 (red) continues to coalesce into a more dot-like
structure.  E.  Late telophase.  Abl::GFP (green) now also coalesces in to a smaller structure
than before (compare with B,C) and surrounds the dot-like Rho1 (red) structure.  F. Co-
localization of Abl::GFP (green) with the telophase markers Anillin (red) and Acetylated
Tubulin (blue).  At mid-telophase, Abl::GFP is enriched between daugther cells, and overlaps
but also extends beyond the domain of anillin localization.  Acetylated tubulin begins to
appear perpendicular to the Abl/Anillin structures.  G. Late telophase.  Abl::GFP (green)
overlaps anillin (red) and is bisected by a more extended domain of acetylated tubulin (blue).
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Fig. 5.2.  An antibody that recognizes activated Drosophila Abl.  A. Alignment of the
peptide sequence from c-Abl used to generate the P(Y412)Abl antibody with sequence from
Drosophila Abl.  Non-identical residues in fly are in italics.  The phosphorylated tyrosine is
underlined.  B.  Western blot from embryonic extracts.  Upper panel- anti Abl blot.  In UAS-
Abl, UAS-Kinase dead Abl, and wild-type, anti-Abl recognizes a doublet at around 180 kDa.
UAS-p185 BCR Abl is not recognized by this antibody due to the presence of mammalian
sequence.  Middle panel- anti P(Y412)Abl blot.  Abl signal (marked with *, arrows mark
cross-reacting bands) is elevated in embryos overexpressing wild-type or active (p185 BCR)
Abl, but not in kinase dead Abl or wild-type embryos.  Lower panel- anti Pnut (loading
control).  C.  P(Y412)Abl recognizes UAS-Abl expressed in engrailed stripes.  D.
P(Y412)Abl recognizes UAS-p185BCRAbl expressed in engrailed stripes. E. P(Y412)Abl
recognizes UAS-p210Abl expressed in engrailed stripes.
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Fig. 5.3.  Sub-cellular localization of Phospho-Abl during embryogenesis.  Wild-type
embryos, stained with P-Abl. A. Gastrualtion, ventral surface.  P-Abl localizes to the apical
cell cortex.  B. Closeup of A showing tricellular junction localization (arrow).  C.  Germband
extension, dorsal surface.  P-Abl outlines both epithelial (lower half) and amnioserosal (wavy
cells in upper half) cells.  D. Germband extension, lateral epidermis, interior section.  Arrow
highlights apical localization of P-Abl in tracheal pits.  E. Dorsal closure, dorsal surface. P-
Abl localizes to the leading edge actin cable (arrow), as well as epithelial and amnioserosal
cells.  F. Closeup of E showing tricellular junction localization (arrow).  G. After dorsal
closure.  P-Abl localizes to the epithelial cell cortex.  H. After dorsal closure, P-Abl localizes
to the axons of the central nervous system
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Fig. 5.4.  Co-localization of P-Abl with Abl::GFP and Ena.  A. Cross-section, gastrulation,
apical up.  Abl::GFP (green) and P-Abl (red) localize prominently to the apices of epithelial
cells (arrows).  B.  Lateral grazing section, germband extension.  Abl::GFP (green) and P-Abl
(red) are enriched between daugther cells (arrow) and at tri-cellular junctions (arrowhead).
C.  Lateral grazing section, germband extension.  Ena (green) and P-Abl (red) co-localize at
tri-cellular junctions.  D. Dorsal grazing section, dorsal closure.  Ena (green) is enriched in
puncta at the leading edge (arrow) and in segmental groove cells (arrowhead).  P-Abl (red) is
not obviously enriched in either of these structures.
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Fig. 5.5.  PVR and Src42 are candidate Abl activators. All embryos express a given UAS
construct under control of engrailed GAL4.  In all merged images, red marks engrailed
staining, and green shows P(Y412)Abl localization.  A.  Overexpression of PVR.  A’. Abl
activation is elevated in active PVR expressing cells.  B.  Phosphotyrosine (P-Y) increases in
PVR expressing cells.  C.  Overexpression of EGFR.  C’.  Abl activation is not elevated
in active EGFR expressing cells.  D.  Phosphotyrosine does not increase in EGFR expressing
cells.  E.  Overexpression of Src42.  E’.  Abl activation increases in active Src expressing
cells.  F.  Phosphotyrosine increases in Src42 expressing cells.  G.  Overexpression of Raf.
G’.  Abl activation does not increase in Raf overexpressing cells.
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CHAPTER 6
DISCUSSION
Building an animal is an intricate process on many levels.  At the tissue level, layers
are internalized, stretched, and compressed.  Within these tissues, cells change shape or
position via different mechanisms.  At a molecular level, the complexity is greater still.  Our
current aim is to understand the interactions between the numerous signaling molecules that
move the structural nuts and bolts of a cell.  Doing so will illuminate the instructions that
direct specific cell shape changes as part of overall tissue reorganization.  Further,
understanding the role of such morphogenesis regulators will contribute to our understanding
of human disease.  In my thesis work, I examined in detail the role of the signaling proteins
Rho1 GTPase and Abl kinase during Drosophila epithelial morphogenesis.  These proteins
regulate specific aspects of cell shape change by interacting with adherens junctions and the
actin cytoskeleton.
Rho GTPase: an integral part of morphogenesis
For the majority of my thesis work, the role of Rho1 GTPase was a recurring theme.
Given the well-documented diversity of Rho GTPases in many cellular functions, it is not
surprising that Rho1 contributes to multiple aspects of morphogenesis regulation.  My work
describes a role for Rho1 in adherens junction regulation, potentially through Cadherin
trafficking.  Further, Rho1 regulation is crucial during ventral furrow formation, downstream
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of RhoGEF2.  The challenge to understanding Rho1 function now is to tease a specific
function away from another.
One key to separating the various roles for Rho GTPases is to focus on the roles of
different Rho regulators and effectors.  For example, the RhoGEF Pebble is a well-known
regulator of Rho during Drosophila cytokinesis (reviewed in O'Keefe et al., 2001).
Similarly, RhoGEF2 appears to participate in a variety of cell shape changes that involve
apical cell constriction (Nikolaidou and Barrett, 2004).  For Rho1’s apparent role in adherens
junction trafficking, a specific RhoGEF has yet to be identified.  Doing so will further help to
elucidate Rho’s connection to adherens junction function.
Examining the targets of Rho will also tease apart Rho’s various functions.  In ventral
furrow formation, Rho kinase appears to be a key target (Dawes-Hoang et al., 2005).  Rho
kinase mutants should be examined in the future to determine if this effector regulates both
myosin accumulation and actin organization.  Another potential Rho1 effector in this process
could be the formin Diaphanous, known to regulate actin structure in Drosophila embryos
(Afshar et al., 2000).  If Rho1 regulates adherens junctions through trafficking, recent work
in cultured cells suggests that Rho kinase may act downstream (Charrasse et al., 2006).
Clearly, use of a variety of regulators and effectors is the key to specificity of Rho function
for a given cellular process.
Abl kinase regulates specific aspects of apical morphogenesis
While Rho function appears quite ubiquitous, Abl kinase appears to act only in
specific processes.  My thesis work confirms through both phenotypic and localization
studies that Abl acts primarily in the apical region of epithelial cells.  Further, while Abl
localizes apically in all epithelia, Abl is required for a subset of apical morphogenetic events.
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This suggests that the localization of Abl activators/effectors may control Abl’s input into a
process.  Two instances of such Abl-dependent processes are constriction of the mesoderm
and elongation of the leading edge cells (Grevengoed et al., 2001).  In both of these events,
Abl’s input into morphogenesis seems to be via regulation of actin structure.  Actin has a
unique localization in each of these tissues- dynamically relocalizing to the apical surface of
constricting mesoderm and to the leading edge cable at dorsal closure.  Future studies of
these two processes and of Abl family proteins in other systems will advance our
understanding of Abl’s utility in the molecular toolkit that acts during morphogenesis.
One apparent key to Abl function is the regulation of Ena.  As during dorsal closure
and blastoderm stages, Ena is an Abl effector in ventral furrow formation.  While Abl’s
regulation of Ena appears central to Abl function, the nature of the Abl/Ena interaction may
be more complex than previously thought. During blastoderm development and in the
mesoderm, Abl accumulates where Ena is not seen.  In later epithelial cells, however, Abl
and active Abl closely localize with Ena.  This suggests that Abl’s negative regulation of Ena
may be more complex than previously thought- repelling Ena in one case while sequestering
it in another.  Future studies of the mechanism by which Abl and Ena interact will clarify the
interaction of these proteins during cytoskeletal remodeling, including whether Abl kinase
activity is necessary.
Other roles and partners for Abl
Additional roles and targets of Drosophila Abl during epithelial morphogenesis
remain to be studied.  For instance, some abl mutant embryos fail in germband retraction and
dorsal closure.  An interesting model for Abl function in these events could be as a
downstream target of integrin-based adhesion.  The evidence for this model in Drosophila is
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twofold: Abl::GFP overlaps with Beta-integrin (Chapter 3) beginning at gastrulation and both
germband retraction (Schock and Perrimon, 2002) and dorsal closure (Narasimha and Brown,
2004) require integrin function.    Further, work in cultured mammalian cells points to a role
for integrin engagement in Abl activation (Lewis et al., 1996), a function that could be
explored in flies using the active Abl antibody.
Another interesting connection between Abl and morphogenesis could involve
regulation of microtubules.  Arg can cross-link actin and microtubules during fibroblast
adhesion (Miller et al., 2004), and Drosophila Abl was recently shown to regulate the
microtubule associated protein Orbit/MAST (Lee et al., 2004).  My work on ventral furrow
formation showed a failure of RhoGEF2-dependent myosin contraction in abl mutants.
Given the model that RhoGEF2 is recruited to microtubule plus ends and stabilized in the
apical cortex in constricting cells (Rogers et al., 2004), an attractive mechanistic model for
Abl function in this process could be as an actin/microtubule cross-linker that indirectly
stabilizes RhoGEF2 in the vicinity of apical actin.
Examining the role of candidate Abl activators will further clarify Abl’s role in
morphogenesis.  Particular activators may act in different contexts.  For instance, PVR is not
expressed in early embryos (Rosin et al., 2004), where Abl clearly is functional.  In contrast,
Src42 localizes to many places in early embryos, including enrichment in the ventral furrow
(Takahashi et al., 2005), suggesting that Src42 may direct the apical activation of Abl in the
mesoderm.  Of course, further study will clarify whether Pvr and Src42 are bona fide Abl
activators.
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Adherens junctions as hubs for signaling activity
Adherens junctions are critical for the maintenance of epithelial integrity.  These cell
adhesion contacts are remodeled during epithelial morphogenesis.  Additionally, many
proteins localize in the vicinity of adherens junctions to direct morphogenetic change.  Our
work in the Drosophila embryo supports this conclusion.  For example, Abl and Ena
localization overlaps adherens junctions in Drosophila epithelia.  Both of these proteins
participate in morphogenesis specifically in the apical domain of cells.  Further, RhoGEF2
exhibits a dramatic relocalization to adherens junctions in apically constricting cells of the
ventral furrow.
While many proteins may localize to adherens junctions, they may not directly act on
junctions, but rather on the cytoskeleton.  This is likely the case with Abl, which via Ena
regulates actin.  abl mutant ventral furrow phenotypes clearly effect actin and do not
resemble those of adherens junction mutants (Dawes-Hoang et al., 2005).  Another
possibility is that a signaling protein acts on both adhesion and the cytoskeleton.   For
instance, Rho1 may regulate Cadherin trafficking but also actin structure at the leading edge
during dorsal closure.  Deciphering the primary targets/mechanisms of actions for other piece
mover proteins is critical in the ongoing efforts to understand how signaling molecules direct
morphogenesis.
Morphing forward
To date, many regulators of morphogenesis have been identified in several systems
and countless processes.  What is important now is to move from lists of genes that are tied
to a process to regulatory networks, explaining how each piece of the puzzle fits together.  It
is important to identify who is in or out of a specific pathway as well as where different
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pathways intersect.  Studying related processes across evolution will further elucidate key
signaling instructions that govern cell shape change.  For example, our study of apical
constriction in gastrulating Drosophila revealed that ventral furrow regulation consists of
inputs into both actin and myosin regulation.  While Abl and Cta contribute to only one of
these inputs, RhoGEF2 cooperates in both.  Further, Abl and RhoGEF2 appear to both
regulate actin, but not as part of the same pathway.  Our work points to conserved roles for
Abl and Rho in actin regulation during ventral furrow formation.  It will be interesting to see
if the same is true for Abl and Rho during vertebrate neural tube closure.  
Morphogenesis and disease
It is rewarding as a scientist to envision how discoveries at a basic research level may
contribute to understanding human disease.  The regulation of morphogenesis relates to
human disease on many levels.  Defects in morphogenesis can give rise to birth defects or
lethality during pregnancy.  Further, failure to properly regulate the cytoskeleton and
adhesion is thought to be a primary step in the progression to cancer.
Neural tube closure defects are the second most common form of birth defect
(reviewed in Detrait et al., 2005). While Folic Acid supplements have been effective in
reducing the incidence of such defects, certain genetic backgrounds in mice appear resistant
to this treatment (reviewed in Juriloff and Harris, 2000). My cross-sectional imaging of the
ventral furrow reinforces the similarity between the internalization of these cells and those of
the vertebrate neural tube.  Given the conserved role for Abl in both of these processes and
the existence of Abl-specific inhibitors, Abl could represent an important therapeutic target
for prevention of neural tube defects.
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Examining Abl’s function also ties into understanding the abnormal activity of this
kinase during chronic myeloid leukemia (CML).  This condition is brought about by the
Philadelphia chromosomal translocation that fuses part of the bcr gene to the extreme N-
terminus of abl coding sequence.  This fusion is thought to relieve auto-inhibitory
interactions in Abl, resulting in an overactive kinase (reviewed in Hantschel and Superti-
Furga, 2004).  Our lab’s work on Abl underscores the role of this kinase in regulation of actin
structure via negative regulation of Ena/VASP.  Studies in cultured mammalian cells show
that in the absence of Ena/VASP, the actin network is more lamellipodial and turns over at a
slower rate, leading to altered migration (reviewed in Sutherland and Way, 2002).  As
changes in migration rates are often a hallmark of cancer cells, this may suggest that
inappropriate Ena/VASP regulation is important along the path to CML.  Not surprisingly,
cells from CML patients have been found to have an altered cytoskeleton and migration rate
(Dong et al., 2003; Salgia et al., 1997).
Finally, improper regulation of adhesion at adherens junctions by Rho GTPases has
also been linked to cancer.  Epithelial tumors constitute the overwhelming majority of human
cancers.  Such tumors are characterized by the de-differentiation of polarized epithelial cells
into invasive cells.  Among the changes required to transform epithelial cells is a loss of cell-
cell contact at adherens junctions (reviewed in Lozano et al., 2003).  Our work and the work
of others supports the idea that Rho GTPase is one of the key stabilizing forces in the
maintenance of cell-cell contact.  Thus, Rho GTPases may identify an important de-
differentiating factor that could play a role in cancer therapy.  An important theme for all of
these studies is to first understand what a protein does when things go right (during normal
development) before investigating what a protein does when things go wrong (in disease).
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